Neuroinflammation and inhibitory synaptic control of cultured premotor circuits by Giacco, Vincenzo
1 
 
Scuola Internazionale Superiore Studi Avanzati 
(SISSA) 
 
 
 
 
Neuroinflammation and inhibitory synaptic 
control of cultured premotor circuits  
 
 
Candidate                                                                                            Supervisor 
Vincenzo Giacco                                                               Prof. Laura Ballerini 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy 
in Neurobiology 
June 12th 2018 
  
2 
 
  
3 
 
Table of contests 
 
ABSTRACT ..............................................................................................................................5 
INTRODUCTION  ...................................................................................................................7 
1. Neuroinflammation and neurodegeneration ............................................................7 
1.1 The immune response in the CNS  ......................................................................8 
2.1 Neuroglia ...........................................................................................................10 
 Microglia ....................................................................................................10 
 Astrocytes ...................................................................................................13 
 Oligodendrocytes .......................................................................................14 
 Schwann cells .............................................................................................15 
1.3 Microglia and astrocytes in neuroinflammation and diseases ...............................16 
1.4 Cytokines network in neuroinflammation .............................................................19 
 Interferons ........................................................................................................19 
 Colony-Stimulating Factors .............................................................................20 
 Transforming Growth Factor-β Family ...........................................................21 
 Tumor Necrosis Factor Family ........................................................................21 
 Interleukin Family ............................................................................................21 
1.5 Inflammation in neurodegenerative and neuroimmunological disorders ..............22 
 Multiple sclerosis .............................................................................................23 
1.6 Neuroinflammation and neuronal activity .............................................................25 
2. Spinal cord networks ................................................................................................27  
2.1 Structure and function of spinal cord .....................................................................27 
 The somatosensory system ..............................................................................28 
 The motor system .............................................................................................29 
2.2 Molecular and cellular development of the spinal cord .........................................30 
 Heterogeneous classes of interneurons during spinal cord development ........31 
 GABAergic and glycinergic changes in the developing spinal networks  .......33 
2.3 Synaptic activity and cytokines effect on the spinal networks ..............................35  
4 
 
3. Organotypic spinal cord cultures ............................................................................ 37 
3.1 Ex-vivo spinal cord model from mouse embryos .................................................. 37  
4. Fast inhibitory synaptic network: the GABAergic transmission ......................... 39 
4.1 GABAA receptors: structural composition and function ....................................... 40 
4.2 GABA ARs post-synaptic organization and plasticity ............................................ 42  
4.3 The dynamic of intracellular chloride regulation................................................... 43  
4.4 Chloride regulation in CNS disorders .................................................................... 45   
AIM OF THE THESIS .......................................................................................................... 48 
MATERIALS, METHODS AND RESULTS ...................................................................... 49 
1. Paper 1: Bridging pro-inflammatory signals, synaptic transmission and protection in 
spinal explants in vitro .................................................................................................... 
2. Paper 2: Neuroinflammation by Cytokines but not by LPS shapes GABAergic 
currents in mouse spinal cord explants culture (MS in preparation) .......................... 63 
CONCLUSION ...................................................................................................................... 89 
REFERENCES ....................................................................................................................... 91 
 
  
5 
 
Abstract 
My PhD project is focused on the impact of neuroinflammation processes in the mouse spinal 
cord, with particular attention to cytokines and their functional role. In particular, I have used 
as model the organotypic spinal cultures, which allowed me to investigate: i. spinal network 
activity changes induced by pro-inflammatory cytokines; ii. resident microglia and astrocytes 
response to inflammatory stress; iii. mechanisms by which pro-inflammatory cytokines 
modulate the inhibitory transmission. The principal aim of my work was to understand the 
crosstalk between neuroinflammation and the spinal pre-motor network. For this purpose, I 
combined electrophysiological and immunofluorescence methods to assess the interneurons 
synaptic activity especially localized in the ventral organotypic cultures from embryonic 
mouse spinal cord.   
I investigated a specific cytokines cocktail (TNF-α, IL-1β, and GM-CSF; CKs) and their 
effects on spontaneous and inhibitory postsynaptic currents (sPSCs and IPSCs). In cultured 
spinal networks, I have observed a progressive increase in the frequency of PSCs and IPSCs 
accompanied by a fastening of GABAergic currents, due to a reduction in the decay time 
constant (τ). This difference in the GABAergic PSCs kinetic properties is maintained in 
miniature PSCs (mPSCs) recorded after CKs treatments, suggesting mechanisms strictly 
associated with post-synaptic modification. The specific CKs modulation of GABAergic 
currents is strengthened by the absence of such a regulation by another danger signal as LPS. 
In this work, I evaluated and compared resident neuroglial cells response to CKs and LPS. 
Microglia and astrocytes show a different activation in the spinal slices. In particular, CKs 
induce an increase of microglia proliferation and astrogliosis followed by decreasing of 
microglia ramification. On the other hand, LPS increases only microglia ramification 
maintaining unaffected the other properties. Regardless the cell morphology, the activation of 
an inflammatory status was confirmed by the presence of cytokines and chemokines release in 
the supernatants in both conditions. 
I investigated the mechanisms by which cytokines speeded up the GABAAR-mediated 
currents, and pharmacologically based electrophysiological experiments strongly indicated the 
presence of a modulation of GABAAR subunit, in particular of α-subunit.  
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In conclusion, my work highlighted the effect of cytokines in compromising the pre-motor 
circuits that may contribute to induce spinal network increased excitability ultimately leading 
to neurodegeneration. 
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Introduction 
 
1. Neuroinflammation and neurodegeneration 
The Central Nervous System (CNS) is characterized by a high structural and functional 
complexity enabling the control of different tasks. CNS high specialization and complexity 
hardly recover upon damage in the adult, thus leading to permanent functional deficits. In many 
cases, CNS dysfunctions are associated with neuroinflammation. 
Neuroinflammation is an important protective mechanism adopted by the organism to repair, 
regenerate and remove damaged cells or pathogens (Kulkarni et al., 2016). Several immune 
and inflammatory cells are involved in reacting to the damaged CNS (Fig. 1). In the CNS, 
neuroinflammation is primarily mediated by microglia, astrocytes, and neurons to be followed 
by T-cells, neutrophils, mast cells, and involves inflammatory mediators such as cytokines and 
chemokines (Shabab et al., 2017). The development of chronic inflammation results in 
progressive neuronal death (Chen et al., 2016). In fact, chronic neuroinflammation plays an 
important role in the onset and progression of several neurodegenerative diseases, as in the 
case of Alzheimer’s disease (AD) and Parkinson’s disease (PD), or Amyotrophic Lateral 
Sclerosis (ALS) and Multiple Sclerosis (MS).  
Neurodegeneration is a pathological condition in which neuronal structure and functions are 
altered, leading to neuronal death and loss of cognitive and motor functions. Despite the 
progression in understanding the mechanisms involved in the neurodegenerative diseases, the 
causes of these disorders are essentially unknown.  
Different factors are implicated in the onset and development of many disorders. Some 
neurodegenerative diseases are associated with a genetic basis (<5%) as in the specific case of 
SOD1 gene mutation related with ALS, α-synuclein with PD, and amyloid precursor protein 
(APP) in AD. These mutations once inherited could contribute partly to the disease symptoms. 
On the other hand, environmental factors are particularly involved in the progression of the 
neurological disorder, as for instance in the MS in which reactive immune response towards 
myelin fibres promote degradation and axonal loss (Ransohoff, 2016; Schwartz and 
Deczkowska, 2016).  
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Figure 1. Mechanisms triggered by neurodegeneration and neuroinflammation disorders.  
a) Resident microglia cell and astrocytes are activated by proteins aggregate which induce the cytokines 
production contributing to the neurodegenerative mechanisms in the brain. Most of the inflammatory cells are 
recruited from the brain without any involvement of leucocytes from the peripheral blood circulation. b) 
Neuroinflammation is triggered by an internal defect such as demyelination which activates mechanisms mediated 
by astrocytes and microglia resulting in the invasion of lymphocytes and monocytes coming from the peripheral 
circulation (Becher et al., 2017).   
1.1 The immune response in the CNS 
In the CNS the first line of defence is accomplished by the Blood-Brain Barrier (BBB), a 
selectively permeable membrane that controls the CNS microenvironment and homeostasis 
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(Fig. 2). The BBB separates the brain from the circulating blood by specialized endothelial 
cells which are attached to each other via peculiar junctions. This tight barrier prevents the 
entrance of infectious agents and toxic factors to protect alteration of the CNS.  
 
 
Figure 2. Structure of the blood barrier in the central nervous system. 
CNS is protected from the external environment by two barriers located around the brain and the choroid plexus. 
The blood-brain barrier (BBB) is composed of endothelial cells and astrocytes which maintain well separated the 
blood circulation and the brain parenchyma. Similar to the BBB, the blood-CSF barrier has a stroma layer between 
blood and CSF which role is to control the leucocytes trafficking and the production of neurotrophic factors 
(Deczkowska et al., 2016). 
In several pathological conditions such as infections, injuries, or traumas, even slight 
alterations of the BBB expose the SNC to molecules that trigger the activation of the innate 
immunity. These molecules include proteins from the bacterial membrane, intracellular 
proteins, and molecules such as ATP, urea and nucleic acid (Kumar et al., 2011) which are 
recognized by germline-encoded pattern recognition receptors (PRRs). Three groups of 
receptors belong to PRRs family: Toll-like receptors (TLRs), Nod-like receptor (NLRs), and 
RIG1-like receptors (RLRs). These receptors expressed by microglia, astrocytes, 
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oligodendrocyte, endothelial cells, and even neurons activate a specific pathway and release 
cytokines mainly involved in disease progression, particularly TNF-α, IL-1β, and INF-γ.  
1.2 Neuroglia 
The term of “neuro-glia” (nerve-cement) was coined for the first time way back in 1858 from 
Rudolph Virchow, a German pathologist. With this name, Virchow denominated all the 
material present in CNS between neurons. Substantially, he described the real “cement” which 
binds the nervous elements together that constitutes a tissue different from the other connective 
tissue (Virchow R, 1978).  
Today, the term neuroglia, better known as glial cells, indicates a number of cells, including 
microglia, astrocytes, oligodendrocytes, and Schwann cells. They are distinguished from each 
other by their different morphology, lineage, properties, and functions. Glial cells play an 
essential role in development, synaptic plasticity, and regeneration, ensuring the highest 
performance for the brain and spinal cord.  
Microglia 
Microglia represent the 5-20% of the total population of glial cells in the entire CNS. These 
cells are considered complementary to macrophages, given their ability to fulfil phagocytosis, 
release cytotoxic factors and begin an immune response (Hanisch and Kettenmann, 2007).  
There are two major functional roles of microglia: immune defence and CNS maintenance 
(Hanisch and Kettenmann, 2007; Colton CA, 2009; Hanisch, 2013). Microglia are sentinels 
that recognise pathogens invasion and damage, under the inflammatory condition, they react 
but also tone down the damage to the CNS, delete debris, dead cells, and support remodelling 
and tissue repair (Lloyd et al., 2017). Another feature of microglia are their ability in 
controlling neuronal proliferation and differentiation (Graeber et al., 2010; Hughes et al., 
2012), besides contributing to synaptic structures formation and elimination (Tremblay et al., 
2010). 
The presence of microglial cells have been described for the first time during early 
development, suggesting that microglia arise from embryonic progenitors. These progenitors 
were first proposed to be meningeal macrophages infiltrating into the brain during early 
embryonic development (Ginhoux et al., 2013).  
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At murine embryonic stage E8.5, yolk sac (YS) produces early primordial macrophages and 
erythrocytes as part of the process of primitive hematopoiesis. In addition, multilineage 
erythromyeloid progenitors (EMP) and lymphomyeloid progenitors also emerge in the YS as 
a second wave (Fig. 3). Later, at E9.5 YS macrophages migrate to colonize the brain rudiment, 
become microglial precursors, and starting from E13 they give rise to microglial cells during 
the brain development. On the other hand, the generation of definitive hematopoietic stem cells 
(HSCs) occurs in the aorta–gonad–mesonephros (AGM) region of the embryo around E10.5. 
These AGM-derived HSCs then migrate to the foetal liver (FL) and bone marrow (BM) and 
differentiate into all lineages (Cumano and Godin, 2007). Afterwards, HSC-derived myeloid 
cells, such as monocytes, are produced abundantly in the FL only from E12.5/E13.5 (Fig. 3). 
As a result, the brain contains YS-derived macrophages, but not HSC or maternal 
macrophages, suggesting that microglia have different origins from the other haematopoiesis 
lineages.  
 
Figure 3.  Microglial and hematopoiesis cells differentiation during development.  
In the early stage of mice development macrophages are originated from the yolk sac (YC). Later, they migrate 
through the blood to reach and colonize the rudimental brain. Here, YC-macrophage differentiates in microglia 
together with the brain maturation (Ginhoux et al., 2013). In parallel, from the foetal liver (FL) and later from the 
bone marrow (BM), monocytes migrate in the blood through which they can reach any tissue and organs. In 
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addition, inflammatory brain stimuli can recruit blood circulating monocytes, which after reaching the brain are 
able to offer support in re-establishing the physiological conditions (Ginhoux et al., 2013).   
A similar pattern of events may occur in humans. In human foetuses, microglia-like cells with 
a range of different morphologies can be detected as early as 13 weeks of estimated gestational 
age (Hutchins et al., 1990). However, it appears that maturation of the microglial compartment 
is ongoing throughout the majority of gestation. Colonization of the spinal cord begins at 
around 9 weeks, the major influx and distribution of microglia commence at about 16 weeks, 
and ramified microglia take up to 22 weeks to become evenly distributed within the 
intermediate zone (Rezaie and Male 1999; Rezaie et al., 2005). In fact, it is only close to term, 
at 35 weeks, that well-differentiated microglial populations can be detected within the 
developing human brain (Esiri et al., 1991; Rezaie and Male 2002; Rezaie et al., 2005; Verney 
et al., 2010). 
In physiological conditions, microglia are distributed ubiquitously throughout the CNS, with 
the highest densities in the hippocampal formation, the olfactory telencephalon, and in some 
areas of the basal ganglia, such as the substantia nigra. One of the main peculiarities of 
microglia are the ability in changing their morphology and appearance upon certain 
physiological or pathological states. This morphology, mainly characterized by the extent of 
branching patterns, differs among brain regions, or when comparing cells located in the grey 
or white matter (Lawson et al., 1990). The microglial immunophenotype commonly associated 
with resting or activated microglia is influenced by the chemical composition of the 
microenvironment, reflecting the physiological or pathological conditions of the surrounding 
tissue. In the healthy adult brain, microglia are usually highly branched (ramified) with a small 
amount of perinuclear cytoplasm and a small, dense, heterochromatic nucleus. 
This structure is associated with resting microglia (quiescent) (Fig. 4). On the opposite, in 
pathological conditions in particular associated with inflammation, microglia reduce the 
branches toward the amoeboid type (reactivate). In addition, microglia produce neurotoxic 
molecules, such as nitric oxide, glutamate, reactive oxygen and nitrogen species, and pro-
inflammatory cytokines, contributing to the so-called secondary damage following injured or 
diseased CNS (Leong and Ling, 1992).  
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Figure 4. Different microglia morphology 
Resting microglia are characterized by long a numerous branches which confer them the typical ramified shape. 
Inflammatory and injured stimuli induce microglia activation which is represented by an amoeboid morphology, 
promoting the phagocytosis of debris and dead cells. Moreover, microglia can active mechanisms in order to 
deteriorate their body and became dystrophic microglia. (Ransohoff, 2016). 
Astrocytes  
In the nineteenth century, two distinct classes of astrocytes were identified for the first time: 
protoplasmic astrocytes and fibrous astrocytes (Andriezen, 1893). The protoplasmic astrocytes 
are distributed homogenously within cortical grey matter, appearing as complex structures with 
numerous fine processes. Whereas fibrous astrocytes are less complex and organized along 
white matter area with fewer branching processes. Later studies reported the presence of 
specialized astrocytes within different brain area: the Bergmann glia of the cerebellum, or the 
Muller cells of the retina (Kettenmann and Verkhratsky, 2008).  
Glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed by 
astrocytes, has been used to identify astrocytes within the SNC (Eng, 1985) although it is 
well known that not all types of astrocytes express this marker. 
Astrocytes have a plethora of functions, from neuronal support during development, 
maturation and injuries in the CNS, to promoting forms of synaptic signalling and plasticity. 
Astrocytes can be activated thus becoming larger and up-regulating GFAP and other 
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intermediated filament proteins (Pekny and Nilsson, 2005). This mechanism promotes 
astrocytes mobility, in order to reach and contact active synapses.  
The different classes of astrocytes originate from glial progenitor cells. Gliogenesis occurs in 
the perinatal phase in the germinal niches of the CNS, the ventricular (VZ) and subventricular 
zones (SVZ) (Levison et al., 1999). Radial cells in the VZ and glial progenitor cells in the SVZ 
develop into distinct pools of astrocytes. Radial cells are multipotent and persist also 
postnatally, giving rise to a subset of cortical astrocytes (Malatesta et al., 2003; Goldman, 
1995). Alternatively, astrocytes are generated from distal-less homeobox 2 (Dlx2) glial 
progenitor cells, and postnatally from NG2+ glial progenitor cells (Marshall and Goldman, 
2002). This process governs the formation of protoplasmic, cortical and white matter astrocytes 
(Beckervordersandforth et al., 2010). 
Likewise, in the spinal cord astrocytes follow the same path. Especially, Olig2+ progenitors 
arise from a particular ventricular zone of the spinal cord named the motor neuron progenitor 
domain (pMN), which give rise to ventral horn astrocytes (Masahira et al., 2006). Recent 
studies have demonstrated three distinct domains of the ventral ventricular zone, which 
generate distinct white matter astrocyte subpopulations in the spinal cord (Hochstim et al., 
2008).  
Oligodendrocytes  
Oligodendrocytes are defined as the cells that produce the myelin sheaths around the axons of 
several neurons. Rio Hortega classified oligodendrocytes into types I to IV, according to the 
characteristics of the number and orientation of their cellular processes, the shape and size of 
their soma, the size of the axons they were associated with, and their distributions within the 
CNS (Simons and Nave, 2015).  
Type I and II oligodendrocytes are quite similar. They have more than three fine primary 
processes that myelinate 10-30 axons < 2 μm in diameter. Type III oligodendrocytes have large 
cell bodies with primary processes that branch and myelinate less than five axons, forming a 
sheath with a diameters ranging from 4 to 15 μm. They are mainly localized in the cerebral and 
cerebellar peduncles, the medulla oblongata, and the spinal cord. Quite similar, type IV units 
are formed by a single long myelin sheath over large-diameter fibres which are found near the 
entrance of nerve roots into the CNS (Simons and Nave, 2015). 
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Differences among large- and small-diameter fibres are mainly due to their protein 
composition (Hildebrand et al., 1993). In fact, myelin basic protein (MBP) and proteolipid 
protein (PLP) are expressed more intensely in small- and large-diameter fibres, respectively 
(Hartman et al., 1982). Moreover, differences are also identified in the adult rat anterior 
medullary velum (Butt and Berry, 2000), concerning of the expression of carbonic anhydrase 
(CA) II and the S-isoform of myelin-associated glycoprotein (MAG). 
During development and maturation, the four classes of oligodendrocytes are derived from 
precursors named Oligodendrocyte Progenitor Cells (OPCs) (Butt et al., 1997). Type III/IV 
oligodendrocytes that differentiate prior to birth, myelinate the large-diameter fibres (≥4 μm) 
early in development. Whereas type I/II oligodendrocytes that differentiate in the first postnatal 
weeks, myelinate the small-diameter fibres (≤2 μm) later in development. Oligodendrocytes 
initially contact a large number of immature thin axons, and most of these processes are lost 
during myelination. In addition, another class of progenitors is associated with 
oligodendrocytes generated during development and the following demyelination in the adult 
brain (Dawson et al., 2000). These cells called NG2-glia for the expression of the NG2 
chondroitin sulfate proteoglycan a potent inhibitor of axon regeneration carry out a principal 
role during injuries protecting the surrounding neurons from further damage (Butt and Berry, 
2000). 
Schwann cells 
The major population of peripheral glial cells is represented by the Schwann cells which are 
similar to oligodendrocytes in terms of structure, molecular composition and functions. Two 
main populations are derived from neural crest, the myelinating and not myelinating Schwann 
cells, distinguished by their ability to contact group of small or one large axon (Dong et al., 
1999). Schwann cells have a peculiar role in forming myelin, a specialized structure that allows 
the conduction of action potentials. In particular, they are responsible for maintaining the 
internodal insulating myelin sheath as well as to the structural and molecular organization of 
the node of Ranvier (Bennett et al., 1997). Other kinds of Schwann cells with different role 
have been described; the perisynaptic Schwann cell of the neuromuscular junction and terminal 
Schwann cell-like cells of the sensory system (Dong et al., 1999). 
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The Schwann cells lineage start from Schwann cell precursors originate from neural crest cells. 
These precursors give rise to immature Schwann cells in a process that starts after 3 weeks of 
mouse embryonic development around birth. Hence, three major developmental steps lead to 
the maturation of Schwann cells after leaving the neuronal crest. Since crest cells can generate 
several cell types, the first steps involve a fate choice in which kind of cells it should become. 
The second transition, in contrast, represents lineage progression that Schwann cell precursors 
are fated only to become Schwann cells or die by programmed cell death. The last stage 
provides the differentiation in myelinated or not myelinated cells (Lobsiger et al., 2002).   
1.3 Microglia and astrocytes in neuroinflammation and diseases  
Microglia mediate immune and inflammatory responses in the CNS. When the brain is injured 
or diseased, the ramified microglia tune their morphology, via retracting their processes and 
increasing their volume (Fig. 5). In response to microenvironment stimuli, microglia can take 
two different fates: pro-inflammatory or anti-inflammatory phenotypes. These phenotypes are 
highlighted by upregulation of specific receptors and soluble molecules; CD16 Fc receptors, 
CD32, CD64, CD86, IL-1β, IL-6, IL-12, IL-23, tumor necrosis factor (TNF)-α, inducible nitric 
oxide synthase (iNOS), and chemokine for the pro-inflammatory state; arginase (Arg)-1, 
mannose receptor (CD206), insulin-like growth factor (IGF)-1, triggering receptor expressed 
on myeloid cells 2 (TREM2), chitinase 3-like 3 (Ym-1) for the anti-inflammatory phenotype 
(Jha et al., 2016).  
17 
 
 
Figure 5.  The synergic work between microglia and astrocytes in diseases 
Changes in microenvironment cause the activation of microglia and astrocytes, altering neuronal functions by 
releasing cytokines and chemokines. In physiological conditions, microglia is in a quiescent status useful for 
homeostasis processes. Once activated by stimuli coming from pathogenic agents, microglia in the first instance 
induce the weakness of neuronal synapses, contributing later to neuronal dysfunction (Sankowski et al., 2015). 
In damaged or reactive tissue, microglia proliferate in response to specific factors such as 
macrophage-colony stimulating factors (M-CSF), granulocyte macrophage-colony stimulating 
factors (GM-CSF), multi-CSF [interleukin-3 (IL-3)], microglial mitogen-1 (MM1), and 
microglial mitogen-2 (MM2) (Giulian and Ingeman,1988; Giulian et al., 1991). 
The expression of the chemokine receptors such as CCR1, CCR2, CCR3, CCR5, CXCR4, and 
CX3CR1, allow the microglia to move during the active state, in order to reach the 
inflammatory area (Gebicke-Haerter et al., 2001). 
When microglia are activated in response to specific stimuli which involve debris and dying 
cells, they transform themselves into phagocytes, in order to engulf dead neurons and damaged 
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tissue. The presence of phagocytes has been observed in AD, PD, MS, ischemia, and trauma. 
In addition, in this activated state microglia produce and secrete a variety of deleterious factors 
including reactive oxygen species (ROS). Thus, one of the more toxic is represented by the 
nitric oxide (NO) that in turn reacts with superoxide anion to produce peroxynitrite. These 
radicals inhibit respiratory enzymes, oxidize the SH group of proteins, and enhance DNA 
injury, finally resulting in neuronal cell death. In the AD β-amyloid, in the presence of 
interferon-γ (INFγ), synergistically stimulates the production of NO and TNF-α in microglia. 
Furthermore, TNF-α causes cell death and, for instance, oligodendrocytes and myelin give rise 
to the inflammation reaction typically associated with MS (Liu et al., 1998).  
On the opposite, microglia may play a protective role in the pathological condition, including 
spinal cord injuries, compression injuries, and ischemia (Dougherty et al., 2000; Ikeda et al., 
2001; Lee et al., 2002). Even in this case activated microglia release a specific class of 
neuroprotective factors and cytokines.   
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-
3), and NT-4/5 belong to the neurotrophins family which plays an essential protective role on 
various types of neurons in the CNS and the peripheral nervous system (PNS). Furthermore, 
other factors such as fibroblast growth factor 2 (FGF2: bFGF), insulin-like growth factor-I 
(IGF-I), IGF-II, and hepatocyte growth factor (HGF) promote neuronal survival in various 
types of neurons in pathological conditions.  
Astrocytes are involved in many important processes such as controlling the environment by 
regulating pH, ion homeostasis, blood flow, and modulating oxidative stress. Together with 
microglia, astrocytes are involved in the neuroinflammatory response. After specific signals 
such as injury or damage, astrocytes rapidly induce important changes in their morphology and 
function, reminiscent of what observed for microglial cells. Reactive gliosis is a self-
perpetuating process by which astrocytes may also exacerbate the injury, instead of protecting 
the damaged tissue. Thus, when astrocytes lose their helpful properties, they contribute to 
neurodegenerative mechanisms (Steardo et al., 2015). 
The mechanisms leading to the activation of these cells are actually unclear, and many factors 
that are involved in neurodegenerative diseases can trigger the response of these cells. As 
microglial cells, astrocytes also can phagocytose and degrade amyloid-beta in AD.  
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1.4 Cytokines network in neuroinflammation 
Cytokines are small proteins that are involved in several cells signalling such as cell growth 
and differentiation, tissue homeostasis and repair, and immune and inflammatory responses in 
the CNS. In fact, they regulate molecules that modify the neuronal microenvironment. In 
addition, cytokines are pleiotropic molecules able to induce the production of other cytokines, 
initiating a complex mechanism of action (Boulanger, 2009; Benveniste, 1998).  
Most of our comprehension of the effects of cytokine release in the nervous system has been 
obtained by studies in primary cultures and in animal models of severe neurological diseases. 
The latter include experimental autoimmune encephalomyelitis (EAE) models for the 
inflammatory, de-myelinating diseases multiple sclerosis; models of chronic 
neurodegenerative disorders, such as AD and prion disease; and SOD1 mutant mice, a model 
for ALS (Glass et al., 2010; Chen et al., 2016). Many studies have been conducted using human 
brain material or cerebrospinal fluid (CSF) from neurological patients, providing important 
knowledge on the role of cytokines in MS (Czubowicz et al., 2017; Burm et al., 2016). On the 
other hand, in vitro studies often generated conflicting results on cytokine sources and targets 
in the CNS, owing to the fact that astrocytes and microglia cultures are able to influence each 
other and neuronal cultures without the contribution of the peripheral system.  
Interferons 
The interferons (IFNs) are a family of proteins produced and released in response to pathogens 
infections. They are classified into two different types: the type I composed by interferon-α 
and -β (IFN-α/β), and type II associated with interferon-γ (IFN-γ). The type I is the product of 
a combination of genes that are produced by many cell types in response to viruses or double-
stranded RNA. Alternatively, type II is the product of a single gene mainly produced by CD8+ 
cytotoxic T cells, a subset of CD4+ T helper cells (Th1), and natural killer (NK) cells. 
IFN-α/β are released by glial cells following the contact with viruses and induce an antiviral 
resistance from CNS cells. In addition, they have also been detected in reactive microglia and 
astrocytes during neurodegenerative processes (Akiyama et al., 1994; Rho et al., 1995). 
Furthermore, both subtypes are used in the therapy of many neuroinflammatory dysfunctions; 
lethal neurotropic viral infection and MS, respectively (Wang et al., 2002a).  
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Contrarily from the previous ones, IFN-γ plays a protective role against neurotropic pathogens.  
In particular, it has been found in high levels in inflammatory pathologies in which are involved 
demyelination and neurodegeneration (Owens et al., 2001; Wang et al., 2002a). In addition, 
the presence of IFN-γ is supported by tissue infiltration and activation of NK, CD8+ cytotoxic, 
and Th1-type T cells (Owens et al., 2001).  
When INF-γ binds to specific microglia receptors, it activates a signal transduction cascade 
which induces the transcription of several immune genes via the transcription factor STAT-1. 
Moreover, IFN-γ potentiates the production of cytokines, chemokines, proteases, NO, and 
ROS, during activation of microglia-mediated by lipopolysaccharide (LPS) and CD40 ligation. 
In addition, IFN-γ acts also on astrocytes and Schwann cells, promoting expression of major 
histocompatibility complex (MHC) and adhesion molecules. The opposite effects exerted by 
INF-γ is chiefly attributable to its activity expressed at local and system level. Locally, INF-γ 
plays a pro-inflammatory role, while at the systemic level it exerts immunosuppressive and 
protective effects, observed especially in EAE model. In particular, a downstream 
immunosuppressive suggested effector molecule is NO, usually induced by INF-γ (Duong et 
al., 1994; Ferber et al., 1996; Willenborg et al., 1996). 
Colony-Stimulating Factors 
Colony-stimulating factors (CSFs) are hematopoietic cytokines that regulate the growth and 
differentiation of bone marrow progenitor cells. IL-3, macrophage-CSF (M-CSF), 
granulocyte-macrophage CSF (GM-CSF), and granulocyte-CSF (G-CSF) are included in this 
class of cytokines. M-CSF is released during infectious, autoimmune, and neurodegenerative 
diseases and together with GM-CSF stimulate microglia proliferation, differentiation, and 
activation in health and disease conditions (Raivich et al., 1999). Besides, GM-CSF is 
increased in microglia following nerve injury, promoting phagocytic capability and antigen-
presenting function (Re et al., 2002). Furthermore, IL-3 supports the proliferation of microglia 
and may serve as a neurotrophic/neuroprotective factor, highly accumulated during EAE and 
in peripheral neuropathies. 
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Transforming Growth Factor-β Family 
Additional cytokines that regulate the cell proliferation, differentiation, migration, and 
apoptosis are called transforming growth factor-β (TGF-β). These include TGF-βs, bone 
morphogenetic proteins, and activins. Three mammalian TGF-β isoforms, TGF-β1, -β2 and -
β3, are principally expressed in the SNC that usually interact with at least three receptors.  All 
three TGF-β isoforms have been detected in macrophages/microglia and reactive astrocytes in 
multiple sclerosis lesions. In particular, TGF-β1 mRNA is expressed predominantly in an area 
with leukocytes and microglia after brain injury and in EAE (Kiefer et al., 1998). In addition, 
also Schwann cells increase the TGF-β1 mRNA after peripheral nerve lesion, whereas in 
Alzheimer’s, Parkinson’s, and prion diseases, high level of TGF-β1 and/or TGF-β2 isoform 
are increased. On the contrary, studies conducted on animal model have revealed that TGF-β 
could also have anti-inflammatory and protective effects (Owens et al., 2001). 
Tumor Necrosis Factor Family 
The Tumor Necrosis Factor Family comprises 20 members mainly involved in the regulation 
of immune responses, inflammation, tissue homeostasis, and development. TNF is principally 
produced by macrophage and its action occurs after binding to functionally distinct receptors: 
TNFR1 (p55 TNF receptor) and TNFR2 (p75 TNF receptor). The most expressed isoform in 
the CNS is TNF-α which induces synthesis of adhesion molecules and chemokines implicated 
in leukocyte recruitment, cell proliferation, and apoptosis. 
TNF-α plays a role in microglia activation contributing to the pathogenesis of multiple 
sclerosis, EAE (Centonze et al., 2009; Owens et al., 2001), and to early neuronal injury 
following acute brain damage (Allan and Rothwell, 2001). One of the major potent stimuli for 
induction of TNF-α in microglia is mediated by lipopolysaccharide (LPS) through binding and 
activation of Toll-like receptors (TLR)-4 (Aloisi, 2001). In contrast, it has been shown that 
TNF-α exhibit distinct functions that can be beneficial as well (Kruglov et al., 2011). 
Interleukin Family 
Interleukin family are composed by a large mixture of cytokines with a different role as pro- 
and anti-inflammatory effects such as interleukin-1, -6, -17, and  Interleukin-4, -10, -13, 
respectively. 
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Interleukin-1 (IL-1) comprises two molecules, IL-1α and IL-1β which have similar affinity for 
the type I IL-1 receptor (IL-1R). Both IL-1 are produced as precursors called pro-IL-1 that are 
cleaved by the enzyme which in turn generate the final active molecule. IL-1 is a pro-
inflammatory cytokine that is produced predominantly by monocyte/macrophage after binding 
to the IL-1R, resulting in the amplification of the inflammatory responses. 
Interleukin-4 (IL-4) is produced by mature Th2 cells, mast cells and basophil. It is released in 
response to allergic diseases and it has a crucial role as in suppressing macrophage activation. 
Many levels of this cytokine have also been detected in autoimmune diseases such as MS and 
EAE model (Owens et al., 2001). Their protective role is due to its ability to inhibit NO and 
pro-inflammatory cytokines and to stimulate NGF releasing (Chao et al., 1993).   
Members of the interleukin-6 (IL-6) family comprises LIF, IL-6, IL-11, ciliary neurotrophic 
factor (CNTF), oncostatin M (OSM), cardiotrophin-1, and growth-promoting activity. The 
principal member is represented by IL-6 whose functions include pro-inflammatory actions 
and regulation of hematopoiesis, B cell growth, and antibody production. On the other hand, it 
can also act as an anti-inflammatory cytokine, blocking the strong production of pro-
inflammatory molecules. The IL-6 receptor is expressed in neurons and astrocytes and is 
increased during CNS inflammation. 
Interleukin-10 (IL-10) is a cytokine with major immunosuppressive and anti-inflammatory 
activities that downregulates cellular immunity by acting directly on T cells. In particular, IL-
10 production is induced in following infection and acute injury and during autoimmunity. In 
vitro, IL-10 inhibits the ability of microglia to function as antigen-presenting cells and to 
produce pro-inflammatory mediators (Aloisi, 2001).  
1.5 Inflammation in neurodegenerative and neuroimmunological disorders 
Neuroinflammation is a peculiar condition characterized by several sequential signals which 
in turn induce the release of cytokines and inflammatory mediators as a result of the activation 
of microglia and astrocytes. There is increasing evidence that neuroinflammation might 
contribute to the increase and the progression of several neurodegenerative disorders (Glass et 
al., 2010). One of the major challenges for scientists in this field is to understand deeply the 
mechanisms involved in the neuroinflammation in order to develop new strategies and 
therapies. One important example is represented by MS. 
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Multiple Sclerosis (MS) 
Different from AD, PD, and ALS, MS is an autoimmune and not hereditary disease 
characterized by inflammation, demyelination, and axon degeneration in the CNS (Fig. 6). The 
pathology occurs when immune system cells trigger an inflammatory response toward the 
myelin sheath. Afterwards, the infiltration of lymphocytes, the increasing in microglia and 
astrocytes, and demyelination into the perivascular region of the brain and spinal cord white 
matter promote axonal degeneration and neuronal loss (Lassmann et al., 2001; Frohman et al., 
2006). The symptoms of MS are associated with defects in sensation and in the motor, 
autonomic, visual, and cognitive systems. 
MS is typically diagnosed by supporting medical imaging and laboratory testing. In fact, 
magnetic resonance imaging (MRI) of the brain and spinal tissue may show plaques or lesions 
associated with demyelinated neurons.  
The development of MS is thought to be principally due to environmental factors, triggering 
an autoimmune response that targets the myelin sheath surrounding nerves (Fig. 6). 
Since MS is not considered a hereditary disease, its pathogenesis is closely correlated with 
viral and bacterial infections because regions of pathogen-associated proteins resemble myelin 
proteins, such as MBP. The onset of the disease occurs when naïve T cells recognize as antigen 
MBP presented by dendritic cells, macrophages, and microglia. A crucial role in the 
pathogenesis of MS is given by Th17 cells a subset of Th1 helper T cells (Cua et al., 2003). 
Th17 cells secrete the pro-inflammatory cytokine IL-17 that plays a key role in infection by 
pathogens (Korn et al., 2009).  More in detail, the demyelination phenomenon is due to the 
loss of oligodendrocytes, resulting in the breakdown of the axons and loss of electrical signals 
efficient propagation. In the majority of cases, remyelination could take place in early phases 
of the disease, but the oligodendrocytes are unable to restore completely the myelin sheath. 
Furthermore, repeated attacks toward myelin increase the damage around the axons, inducing 
the formation of new plaques (Chari, 2007; Compston and Coles, 2002).  
EAE animal model has been induced with peptide sequences from infectious agents that share 
structural homology with myelin components (Libbey and Fujinami, 2010).  
Integrin α4β1 (VLA4) is an adhesion molecule that allows autoreactive T cells to break the 
BBB and migrate into the brain parenchyma. In fact, an antibody directed against very late 
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VLA-4 are used as a therapeutic strategy to inhibit EAE and reduces the frequency of lesion 
formation in MS (Miller et al., 2003).  
 
 
Figure 6. Neuroinflammatory mechanisms in the neurodegenerative diseases. 
Neurodegenerative diseases such as AD, PD, ALS, and MS involve inflammatory mechanisms which contribute 
to degeneration and neuronal death. Different damage stimulate activation of both microglia and astrocytes which 
release several inflammatory factors, including NO, cytokines, chemokines, and ATP. These neuroinflammatory 
agents are crucial for activation of immune cells, recruitment of peripheral blood cells, and neuronal-glial 
communication (Glass et al., 2010). 
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1.6 Neuroinflammation and neuronal activity 
 
           
Figure 7. Cytokines action on ionotropic and metabotropic receptors. 
TNF-α and IL-1β are able to act different effects on AMPA and GABA receptors located in the separate area in 
the SNC. In particular, thanks to the modification in increasing or decreasing of the receptors expressed on 
neurons, cytokines are able to influence the frequency of the neuronal currents signal. Moreover, many evidences 
have demonstrated a further action operated exclusively by TNF-α on the NMDA receptors (Schäfers and Sorkin, 
2008) 
Astrocytes and microglia contribute to the development, plasticity and maintenance of 
neuronal circuits controlling neuronal signalling. In response to changes in the environment, 
activated microglia release NO, trophic factors, or cytokines, all known to control neuronal 
function and synaptic transmission. Studies conducted on neuronal cultures or acute brain 
slices stimulated by LPS have shown an increase of the excitatory post-synaptic currents 
(EPSCs) (Pascual et al., 2012). In fact, LPS-toll-like receptor 4 (TLR4) microglia activation 
release ATP that induce astrocytes-glutamate releases. As a result, glutamate enhances the 
AMPA glutamate receptor-mediated PSCs frequency giving to microglia a specific role in the 
modulation of excitatory neurotransmission (Pascual et al., 2012). In addition, ATP can also 
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increase miniature EPSCs (mEPSCs) frequency in hippocampal cultures apparently regulating 
structural features of synapses such as the probability of presynaptic vesicle release (Antonucci 
et al., 2012). 
Pro-inflammatory cytokines may also specifically interact with receptor and ion channels 
regulating neuronal excitability, synaptic plasticity and injury (Fig. 7).  
The pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) was found to initiate the 
activation cascade of other cytokines and growth factors (Schäfers and Sorkin, 2008). In 
addition, TNF-α induces an increase in the expression on neurons surface of AMPA receptors 
(AMPARs). In fact, blockade of TNF-α signalling reduces the surface level of AMPARs, 
suggesting that TNF-α plays a crucial role in the regulation of synaptic strength at excitatory 
synapses (Tancredi et al., 1992; Beattie et al., 2002). Moreover, additional TNF-α effects are 
observed also on the GABAA receptors, whose expression is reduced on the surface of 
hippocampal neurons (Stellwagen et al., 2005). In particular, through the TNFR1, TNF-α is 
able to regulate both AMPA and GABAA receptors trafficking by controlling mechanism of 
exocytosis and endocytosis, resulting in the alteration of excitatory and inhibitory transmission 
(Stellwagen et al., 2005). Furthermore, several effects on the expression of NMDA receptor 
are known as well (Wheeler et al., 2009).  
Interleukin-1β (IL-1β) is another potent pro-inflammatory cytokine that is produced and 
secreted under conditions that are associated with inflammation and degeneration. Similar to 
TNF-α, IL-1β is able to affect glutamate and GABA receptors, increasing the NMDA- and 
reducing GABAA-mediated transmission. In EAE similar changes in neurotransmission are 
reported to occur in the cerebellum where pro-inflammatory cytokines, in particular, IL-1β, are 
released from infiltrated lymphocytes (Mandolesi et al., 2015). On the contrary, IL-1β inhibits 
the activity of preoptic area/anterior hypothalamus neurons by increasing the presynaptic 
release of GABA through IL-1R signalling (Tabarean et al., 2006).  
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2. Spinal cord networks  
2.1 Structure and function of the spinal cord 
The spinal cord is considered as a gateway for information transfer between the peripheral 
body and the brain consisting of complex neuronal circuits that integrate and coordinate 
sensory, motor and autonomic functions (Hochman, 2007).  
The spinal cord is organized in segments and each segment is associated with a group of 
sensory neurons, whose cell bodies form the dorsal roots ganglia (DRG), from which axons 
leave to reach the periphery. In humans, depending on where they are localized, these segments 
are divided into cervical, thoracic, lumbar, and sacral. In addition, the segmental organization 
within the spinal cord is divided in white and grey matter. White matter surrounds the cord and 
comprises the axon tracts that relay signals to and from the brain and between spinal segments 
and consists almost of myelinated motor and sensory axons. Whereas, the grey matter with 
their peculiar butterfly shape is divided in dorsal and ventral horns that contain sites of 
termination of primary afferent neurons, neurons descending from the brain, interneurons, and 
ascending tract cells projecting to higher CNS levels (Fig. 8). Furthermore, it includes 
microglia, astrocytes, oligodendrocytes and unmyelinated axons as well (Hochman, 2007). 
The several hundred thousand neurons per segment are housed within cytoarchitectonically 
defined anatomical layers called laminae (I-X). Commonly, they are classified into three 
distinct groups: the sensory dorsal horn (laminae I-VI), the intermediate grey (lamina VII), and 
the ventral horn (VII-IX). Motor neurons are located in lamina IX. Moreover, dorsal and 
ventral horn consist of specific and complex systems that differ from each other by their 
distinct function and structure; the sensory system in the dorsal horn and the motor system in 
the ventral horn. 
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Figure 8. Segmental organization of the spinal cord  
Ventral and dorsal horn spinal organization with the presence of white and grey matter. Fibres arise from grey 
matter neurons are spread to the periphery that form the spinal nerves. These nerves send the signals from the 
ventral zone and the stimuli from the periphery come to the dorsal neurons located in the grey matter as well 
(studyblue) 
The somatosensory system 
The somatosensory system is a complex circuit that allows the organism to perceive a wide 
range of heterogeneous signals arising from the periphery thanks to various types of receptors 
widespread in the body. Depending on the type of signal, the receptors are classified in: 
chemoreceptors, thermoreceptors, mechanoreceptors and nociceptors, which translate physical 
stimuli into electrical signals. Moreover, the receptors have a corresponding anatomical 
representation in the spinal cord. Once reached the corresponding neuron, the signal 
transmitted and mapped along sensory pathways that enable a representation of the sensory 
stimulus to specified regions in the cortex (Craig, 2003). 
Somatosensory information starts when stimuli arise from multiple sensory modalities 
converge and interact spatiotemporally on spinal neurons whose response is transmitted to 
other behaviourally relevant regions such as the brain or segmental motor systems. This 
process is controlled by the interneurons that in the dorsal horn are glutamatergic (excitatory) 
and GABA or GABA/glycinergic (inhibitory) interneurons. Primary afferents release 
glutamate as a main neurotransmitter to evoke fast postsynaptic responses composed of early 
AMPA/kainate and late NMDA receptor-mediated components. The continuous signal coming 
from the periphery is well controlled to avoid an excess of transmission. In fact, depolarization 
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of their terminals via negative feedback depression of activated afferents lead to a reduction of 
the neurotransmitter release (Jankowska, 1992). One of the most important roles played by 
dorsal horn is to integrate and relay pain information.  
Glutamate is not the only neurotransmitter involved in the nociceptive signal. In fact, some 
primary afferents are able to co-release a variety of neurotransmitters including substance P, 
calcitonin gene-related peptide, galanin and neuropeptide Y (Millan, 2002). 
The motor system 
The ventral horn is composed by lamina VII-IX whose area is occupied by interneuronal 
populations divided into glutamatergic excitatory neurons and GABA/glycinergic inhibitory 
neurons. In addition, especially in the lamina IX, a wide range of cholinergic motor neurons 
are located, which send axons out of the ventral root to innervate skeletal muscle fibres. These 
motor neurons are divided into two distinct types: α-motor neurons that supply extrafusal 
muscle fibres responsible for movement; γ-motor neurons that innervate intrafusal muscle 
fibres to control muscle tone by regulating the sensitivity of muscle spindles to stretch. 
A peculiar mechanism used by the spinal cord to control the correct functioning of the motor 
outputs is represented by the reflex system. Spinal reflexes are involuntary responses to sensory 
stimuli arising from muscle, joints, and skins to determine stereotyped muscles recruitment. 
The mechanism is due to a correct excitation and inhibition combination between motor and 
interneurons in order to generate flexors and extensors contraction-release (Fig. 9).       
An intrinsic localized neuronal network called central pattern generator (CPG) resides in the 
spinal cord that can generate rhythmic pattern outputs such as walking, breathing, flying, and 
swimming in the absence of sensory inputs or descending commands from the brain cortex. Its 
role is to control the timing and pattern of the muscle activity underlying locomotion. In 
mammals, CPG is situated throughout the ventromedial portion of the lower thoracic and 
lumbar spinal cord (Kiehn and Kjaerulff, 1996; Cowley and Schmidt, 1997; Kremer and Lev-
Tov, 1997). Research conducted on invertebrate species, such as lamprey and Xenopus tadpole, 
has provided a detailed complex structure of CPGs controlling the locomotor movements 
(Grillner, 2003, McLean et al., 2000, Roberts et al., 1998). Despite this, less is known about 
locomotor CPGs in mammals.  
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Figure 9. Motor control network in the spinal cord 
Scheme of the motor system characterized by CPG in order to generate stimuli on motor neurons and interneurons. 
A) The interaction between glutamatergic and GABAergic neurons are able to control neural network for 
presynaptic inhibition of muscle spindle afferents. B) Inhibitory signals from Renshaw cells (R) and inhibitory 
interneurons (Ia) reduce the motor neurons (MN) transmission direct to the peripheral muscles. C) The CPG 
induces the activation of the neuronal network important for the alternation to flexor and extensor muscles 
(Hochman, 2007).   
2.2 Molecular and cellular development of the spinal cord 
Spinal cord development is regulated by specific genes that control cell proliferation, migration 
and patterning as well as later events such as neuronal circuit formation and synaptogenesis 
(Salie et al., 2005). Formation and maturation of spinal cord neurons occur along the three 
basic spatial axes of the embryonic body plan: rostral-caudal, dorsal-ventral, and medial-lateral 
(Fig. 10).  
The rostrocaudal formation is coordinated by a specific gradient of fibroblast growth factor 
(FGF) and retinoic acid (RA) concentrates in the opposite area, caudal and rostral respectively  
(Dasen et al., 2008). Indeed, the medial-lateral axis is separated into progenitor cells, medially, 
and differentiating progeny, laterally. The dorsal-ventral axis is driven ventrally by Sonic 
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hedgehog (Shh) produced by the floorplate, and dorsally by bone morphogenetic proteins 
(BMPs) and Wnts (integrin family) signals from the roof plate. These different morphogens 
form gradients, in turn, activates a specific transcriptional response which proteins can be 
divided into two classes: the class I are inhibited by Shh whereas the class II are contrarily 
activated by Shh (Briscoe et al., 2000; Jessell, 2000; Alaynick et al., 2011). This contrasted 
function between class II and class I proteins allows the consolidation of progenitor identity. 
These progenitor cells are divided into five ventral progenitor domains termed p0, p1, p2, pMN 
and p3, which in turn give rise to interneuron subtypes and motor neurons (Fig. 10). 
The Wnt signalling was also shown to be involved in the formation of DRG sensory neurons 
at early stage (Lee et al., 2004). In vertebrate, Wnt drives the correct direction undertaken by 
axons projection in the rostrocaudal axis in order to reach their target in the brain. In particular, 
this role is mediated by Wnt4 which drives axons toward either posterior or anterior path (Salie 
et al., 2005).  
Heterogeneous classes of interneurons during spinal cord development 
The heterogeneous classes of spinal interneurons play a major role in integrating sensory and 
motor signals in the spinal cord. One of the spinal research challenges is to identify the afferent 
input, output, and the specific role played by the different classes of interneurons in the spinal 
network (Grillner et al., 1998).  
Five classes of genetically distinct ventral neurons are generated by progenitor cells through 
the progressive changes in Shh concentration: V0, V1, V2, V3 interneurons and motor neurons 
(Goulding et al., 2002; Sapir et al., 2004; Alvarez et al., 2005; Nissen et al., 2005). In 
particular, the Shh gradient is driven by homeodomain proteins express by ventral progenitor 
cells; Pax7, Dbx1, Dbx2, Irx3 and Pax6 (Class I); Nkx6.1 and Nkx2.2 (class II) (Briscoe et al., 
2000) (Fig. 10). Post-mitotic neurons generated from these different progenitor domains induce 
differentiation leading to the segregation of the various classes (Jessell, 2000; Goulding et al., 
2002; Nissen et al., 2005). 
From ventral progenitor domains, p0 and p1 derive V0 and V1 that express Evx1/2 and En1 
respectively. Afterwards during the maturation V0 persists whereas the loss of V1 occurs 
gradually. V2 neurons that express Chx10 arise from the p2 domain. Finally, the region 
between floor plate cells and motor neurons generates Sim1 V3 interneurons, defined by 
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expression of Nkx2.2 which derived from cells within the p3 domain (Ericson et al., 1997a; 
Pierani et al., 1999; Briscoe et al., 2000; Jessell, 2000).  
 
Figure 10.  Transcriptional spinal cord development and neuronal formations.  
Different transcriptional factors are responsible for the gradient of proteins such as RA, BMP, and Shh, distributed 
according to the dorsal-ventral axis. The dissimilar progenitors area including p0, p1, p2, pMN, and p3 give rise 
to the specific spinal neurons. In addition, the temporal expression of a wide range of transcriptional factors 
delimits the four segmental spinal zone (Davis-Dusenbery et al., 2014). 
Previous work conducted on spinal neurons demonstrated that a different class of V0 
interneurons is responsible for left-right coordination during locomotion. In fact, glutamatergic 
interneurons located in lamina VIII are capable of generating rhythmic membrane potentials 
in phase with rhythmic motor outputs (Lanuza et al., 2004; Hinckley et al., 2005; Wilson et 
al., 2005). Otherwise, V1 neurons generate Ia inhibitory interneurons as well as Renshaw Cells 
(RC). This class of neurons exhibits different concentration and distribution of the 
GABA/glycine phenotypes from embryos to adult phase. Briefly, embryonic spinal 
interneurons express a high level of GABA, particularly in the ventral horn, which is 
downregulated immediately after birth followed by the increasing of glycinergic interneuron 
(Sauressig et al., 1999; Pierani et al., 2001; Sapir et al., 2004). In addition, it was suggested 
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that V1 neurons take part of the CPG by regulating the duration of locomotor step cycle and 
hence the speed of locomotion in mammals (Gosgnach et al. 2006). V2 are ipsilaterally 
projecting interneurons that extend axons caudally across several segments. They derive from 
progenitors residing dorsally to pMN domain and are divided in two different classes: V2a is 
glutamatergic while V2b is inhibitory which expresses both glycine and GABA. Finally, V3 
interneurons are predominantly glutamatergic neurons expressing Sim1 and VGluT2 which 
arise from the ventral p3 progenitor domain. The 80–85% of these cells project contralaterally 
and a lower proportion remains ipsilateral (Zhang et al., 2008). 
GABAergic and glycinergic changes in the developing spinal networks  
The interplay between the glycinergic and GABAergic synapses changes throughout 
development and is essential for the maturation of the spinal cord. GABA and glycine are 
neurotransmitters involved in the fast synaptic chloride-mediated transmission in the spinal 
cord. From the embryonic to the early postnatal phase, GABA and glycine act as depolarizing 
transmitters due to the high intracellular Cl- concentration (Reichling et al., 1994).   
Crucial for the formation of the interneuronal spinal synaptic connections is the interneurons 
heterogeneity, as well as the essential interaction of excitatory glutamatergic and inhibitory 
GABAergic/glycinergic synaptic transmission (Grillner et al., 1995, 2000).  
In the embryonic mouse spinal cord, the early glycinergic transmission sustains the 
propagation of activity bursts throughout contiguous spinal segments, while their generation 
locally relies on a network formed by motor neurons and GABAergic interneurons (Hanson 
and Landmesser, 2003; Moody and Bosma, 2005). Nevertheless, existing evidence suggests 
that GABA is the most important transmitter in the generation of early prenatal miniature 
currents in rodent motor neurons (Gao et al., 2001).  
During mouse embryogenesis, precisely at E13, glycine levels are higher than GABA ones, 
which progressively augment between E17 and P3, suggesting an already abundant presence 
of glycinergic neurons. Likewise, a gradual increase between E14 and P3 has been noted for 
the GABA neurons too (Miranda-Contreras et al., 2002). An extensive loss of glycinergic 
synapses in addition to a lower pronounced loss of GABAergic synapses occur during the first 
week, precisely between P3 and P7 (Miranda-Contreras et al., 2002).    
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The spatial and temporal development of GABA in the embryonic spinal cord has received 
much attention over the last two decades (Sibilla et al., 2009). The first GABA-
immunoreactive (GABA-ir) somata have been noted in rat at E12.5, following by a transient 
peak in the ventral region differently from the stable GABA-ir density in the dorsal horn (Ma 
et al., 1992, Tran and Phelps, 2000). In addition, the intracellular distribution of glutamic acid 
decarboxylase (GAD) proteins, is shifted from somatic and proximal axon to distal axons and 
terminal-like varicosities during spinal development (Tran et al., 2003). 
In the mouse spinal cord, a slight difference in terms of temporal expression occurs in the 
GABAergic neurons. In fact, the first GABA-ir somata occurs at E11.5, following by a rostro-
caudal gradient of maturation, as well as the increase in the dorsal area (Allain et al., 2004). 
This 1-day delay is essentially due to the different gestation time in the two species: 22 days 
for rat and 19 days for mouse.  
From E13.5 in mouse, the ventral area exhibits a large amount of GABA-ir cells, which is 
partially transposed at E17.5 with a higher GABA-ir density in the dorsal area (Allain et al., 
2004).  After birth, precisely at P0, a drastic reduction of ventral GABA cells occurs, following 
by an increase of the glycine density until the mature phase. In fact, Gao et al. (2001) suggest 
that only neurons expressing GABA phenotype at early stage of development maintain mature 
ventral position. Otherwise, neurons which fail to express GABA may switch phenotype to 
glycine ones. 
The functional role of GABAergic ventral synapses in the embryonic rat spinal cord is related 
to the connection between left and right sides, to the depolarization mediated by GABAA 
receptors, and to the generation of synchronous spontaneous burst of activity (Nakayama et 
al., 2002). Later, from E18.5, glycine receptors take over the role of GABAAR in modulating 
the left-right alternation and mediate the inhibition between the two sides of spinal segments.  
A major of GABAergic and glycinergic function is represented by their excitatory effect 
carried out in the early spinal cord. In fact, during the foetal period, the high intracellular 
concentration of Cl- ions provides a depolarizing activity, resulting in the elevated Ca2+ 
concentration in the spinal neurons (Cherubini et al., 1991; Ziskind-Conhaim, 1998). Using 
this mechanism, GABA and glycine promote neuronal development, control outgrowth and 
differentiation, induce synaptogenesis, crucial for establishing the inhibitory pathway between 
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the rhythm-generating networks (Ziskind-Conhaim, 1998; Phelps et al., 1999; Gao et al., 
2001).   
The switch from the excitatory to the inhibitory transmission of GABA/glycine occurs in the 
entire CNS during development as well as in the maturation of the spinal cord. Especially in 
the mouse, the first evidence of this transition appears after E14.5 persevering for the first two 
weeks (Branchereau et al., 2002; Deply et al., 2008).  The mechanism underlying this switch 
is related to changes in the intracellular Cl- concentration, resulting in the shift from 
depolarizing action of GABA/glycine toward a hyperpolarizing activity. In particular, the 
intracellular Cl- concentration depends on the reverse expression of the Na+-K+-2Cl- co-
transporters isoform 1 (NKCC1) and the K+-2Cl- type 2 co-transporters (KCC2). Typically, 
immature neurons are designated by a higher intracellular Cl- concentration associated with 
higher NKCC1 levels, which profile is completely reversed in mature cells (Fiumelli and 
Woodin, 2007; Ben-Ari et al., 2012).  
2.3 Synaptic activity and cytokines effect on the spinal networks   
Cytokines (CKs) are a large family of proteins released by immune cells in response to tissue 
damage or infections. CKs are powerful neuromodulatory molecules capable of influencing 
synaptic transmission and neuronal excitability (Schäfers and Sorkin, 2008). The effects of 
cytokines on neuronal networks are mediated indirectly, by the release of neuroactive 
molecules from glia, such as neurotransmitters, nitric oxide, and neurotrophins (Allan and 
Roshwell, 2001), or directly by activating neuronal receptors (Viviani et al., 2007; Zhang et 
al., 2014). Regardless the CKs role in triggering the immune response, cytokines exerts 
physiological functions in the immature CNS related to its growth and development. 
Nevertheless, any over-expression of CKs in the tissue leads to neuronal dysfunctions 
associated with neurodegenerative diseases (Glass et al., 2010; Burm et al., 2016; Chen et al., 
2016; Czubowicz et al., 2017).  
In the last decade, research on this subject has led to a deep understanding of the role of CKs 
in driving synaptic function and plasticity. Especially, TNF-α, IL-1β, and IL-6 are attracting 
considerable interest due to their implication in a wide range of synaptic dysfunctions typically 
concerning neurological disorders (Kawasaki et al., 2008; Centonze et al., 2009; Glass et al., 
2010).  
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The focus of recent research has been mainly on TNF-α and IL-1β which affect all principal 
classes of voltage-gated channel (VGCs), such as Na+ channels (Nav), Ca+ channels (Cav) and 
K+ channels (Kv), as well as receptor-operated ionic channels (Vitkovic et al., 2000; Viviani 
et al., 2007).  
TNF-α modulates glutamate and GABA receptors at the neuronal membrane, resulting in 
increased excitotoxicity stress and neuronal death. In particular, TNF-α can exhibit its function 
affecting AMPARs by TNF-R1 (Beattie et al., 2002; Stellwagen et al., 2005; Ferguson et al., 
2008). In addition, TNF-α can also modify extracellular glutamate levels by inducing 
glutamate release from microglia and as well as blocking the astrocytic glutamate re-uptake 
(Zou and Crews, 2005; Takeuchi et al., 2006). 
More recent evidence highlights that acute application or incubation of spinal cord slices with 
TNF-α modulates excitatory and inhibitory synaptic transmission (Kawasaki et al., 2008) 
precisely in the spinal cord dorsal horn (DH). Zhang et al. (2010) have demonstrated that TNF-
α increases the frequency of spontaneous EPSCs (sEPSCs) and also produce a robust decrease 
in the frequency of spontaneous IPSCs (sIPSCs). This enhancement is principally mediated 
through TNF-R1, but not TNF-R2, followed by the activation of neuronal p38 MAPK 
signalling. Hence, GABAergic neurons display a decrease in the spontaneous action potentials 
accompanied by a lowering of Ih currents which provide to the development of neuropathic 
and inflammatory pain. In addition, the main involvement of TNF-α in peripheral nerve injury 
is well delineated. In fact, the control of presynaptic TTX sensitive sodium channel activity by 
TNF-α increased the sensitivity of presynaptic TRPV1 receptors in the primary afferent fibres 
after injury (Spicarova et al., 2011). 
Similar to TNF-α, IL-1β plays a crucial role in synaptic modulation by binding to the IL-1 
receptor 1 (IL-1R1) and regulating the surface expression of NMDA receptors (Viviani et al., 
2003; Gardoni et al., 2011). This leads to the enhancement of Ca2+ influx through NMDARs, 
which in turn promote neuronal network hyperexcitability in vitro DRG and spinal slices 
(Viviani et al., 2003; Yan and Weng, 2013). Different studies conducted on lamina II neurons 
isolated from spinal slices have demonstrated that IL-1β increases frequency and amplitude of 
AMPA receptors, including modulation of NMDARs. Furthermore, IL-1β also reduces 
frequency and amplitude of the sIPSCs acting on GABA- and glycine-induced currents 
(Kawasaki et al., 2008).  
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In the spinal ventral horn, GABA and glycine provide the fast synaptic inhibitory transmission 
essential for motor outputs coordination (Kiehn et al., 1997). The GABA/glycine system 
mature from foetal stages via expressing important changes related to the locomotor spinal 
pattern development. Most of the motor circuits in the ventral spinal cord depend on the 
interplay between excitation mediated by glutamate and inhibition regulated by 
GABA/glycine. Especially in the adult spinal cord, GABA appears to have a crucial role in the 
optimization of motor patterns innervating the motor pattern-generating neurons (Christenson 
et al., 1990). 
CKs with their ability in modulating ion channels, receptors, and synapsis may contribute to 
altering motor synaptic function provoking a wide range of symptoms commonly expressed in 
several neurodegenerative disorders.  
3. Organotypic spinal cord cultures  
3.1 Ex-vivo spinal cord model from mouse embryos  
Organotypic spinal cord slices represent an ex vivo model of segmental microcircuit 
development in which subsets of interneurons can be directly investigated at different growth-
time in vitro (Streit et al., 1991; Gähwiler et al., 1997). Many studies conducted in our 
laboratory have shown that these long-term cultures preserve the basic tissue architecture, 
synaptic connections and dorsal-ventral orientation of the spinal segment (Rosato-Siri et al., 
2002; Avossa et al., 2003; Furlan et al., 2007). Differently, from others in vitro models, the 
organotypic spinal slices have many peculiar characteristics. In fact, processes as 
synaptogenesis and formation of myelin take place in these cultures. In addition, these cultures 
are characterized by a variety of neurons and glial cells and maintain the presence of DRG and 
their incoming output (Streit et al., 1991; Ballerini and Galante, 1998; Ballerini et al., 1999) 
(Fig. 11). Despite the absence of afferent and supraspinal inputs, this preparation represents a 
useful model for studying the dynamics of intra-segmental maturation processes which 
evidently rely on propriospinal circuits. 
In the mouse spinal cord, spontaneous rhythmic activity appears emerges at early 
developmental stages, before the completion of muscle innervations. The generation of this 
activity relies on the depolarizing drive of GABA and glycine receptor-mediated activity, 
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(Hansen and Landmesser, 2003), combined with synaptic short-term depression (O’Donovan 
et al., 1998).  
 
 
Figure 11. Immunocytochemistry of organotypic cultures with the anti-NF-H antibody SMI32 
A) The culture at 8 DIV labelled with SMI32 show processes exiting bilaterally from the ventral part of the slice 
(arrows). DRG cells present in the top part of the picture. B) The culture at 14 DIV show motoneurons located in 
the ventral region, bilaterally to the ventral fissure. C) Slice at 21 DIV notes motor neurons and DRG neurons in 
the ventral horn. All the images show the correct ventral-dorsal orientation typical of the spinal cord (Avossa et 
al., 2003). 
Since ontogeny and functional development of GABAergic interneurons observed in vivo is 
maintained in cultured spinal slices (Avossa et al., 2003; Furlan et al., 2005; Furlan et al., 
2007), validating the crucial importance of GABAergic connections for circuit assembly and 
activity (Barbeau et al., 1999).  
In the organotypic spinal slices, five different types of ventral interneurons have been 
identified, on the basis of their discharge patterns: tonic cells, that fired action potentials (APs) 
without apparent accommodation; adapting cells, that discharged an early burst of APs 
followed by adaptation; delay cells, that generated APs after a lag; irregular cells without 
discernible discharge patterns; transient cells, that generated a single AP only (Furlan et al., 
2007). Interestingly, the distribution of the five neuronal classes is maturation-dependent and 
reflects in addition to the heterogeneous nature of neuronal types of the spinal cord 
(Jankowska, 2001).  
The organotypic spinal model replicates some aspects of the vivo environment (Ravikumar et 
al., 2012). There are several advantages of using this model:  
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i. interneurons are easily visualized based on their shape and localization, allowing to 
conduct electrophysiological patch clamp experiments useful to observe the spinal 
network activity; 
ii. slices maintain the correct ventral-dorsal orientation providing the possibility to focus 
on a specific spinal area; 
iii. the correct structure of the pre-motor circuits is preserved along with the complex 
interplay between interneurons and motor neurons, supported by the DRG and their 
incoming output; 
iv. the ability to reproduce suitable inflammatory responses mediated by microglia, 
astrocytes, and oligodendrocytes following in vitro neuroinflammatory activation; 
v. the advantage of isolating a specific mediated-receptor current, such as excitatory 
(AMPA and NMDA) and inhibitory (GABA and glycine) transmission by 
pharmacological block.        
vi. the possibility to test pharmacological target fundamental for many neuroinflammatory 
diseases. 
Electrophysiological experiments such as patch clamp recordings, local field potential 
recordings and multi-electrode arrays combined with immunohistological tools can detect 
changes in neural mechanisms and activity when interfaced to different pathological 
environments.   
For all these reasons, this model allows elucidating the potential effects due to the alteration of 
spinal network, which is principally responsible for several inflammatory and degenerative 
diseases. 
In summary, the combination of a developing spinal network supported by different cell 
populations, complex synapses, and the interneurons electrical profile make the organotypic 
spinal slices an excellent model to clarify several mechanisms underlying network 
dysfunctions (Rosato-Siri et al., 2002; Avossa et al., 2003; Medelin et al., 2016; Medelin et al, 
2018).  
4. Fast inhibitory synaptic networks: the GABAergic transmission 
Fast inhibitory neurotransmission is modulated by two different neurotransmitters: GABA (γ-
aminobutyric acid) and glycine. GABA plays a crucial role in adjusting several functions 
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including sensory and motor processing, central autonomic control, sleep-wakefulness, 
emotions, and cognition. Moreover, GABA is capable of binding to ionotropic (GABAAR) 
and metabotropic (GABABR) receptors, ubiquitously expressed in the CNS (Barnard et al., 
1998; Bowery et al., 2002). Alteration in the GABAergic system leads to a wide range of 
neurological disorders, such as epilepsy, anxiety, ethanol dependence, and schizophrenia 
(Coulter et al., 2001; Malizia et al., 1999; Morrow et al., 2001; Blum and Mann, 2002). In 
particular, GABAA receptors represent a major site of action for clinically important drugs, 
including benzodiazepines, barbiturates, and some general anaesthetics (Rudolph and 
Antkowiak, 2004), as well as ethanol, and endogenous modulators, notably endozepines 
(Christian et al., 2013) and neurosteroids (Hosie et al., 2006). The endogenous modulators, in 
large part derived from glial cells, are implicated in the regulation of many functions under 
both physiological and pathological conditions.   
4.1 GABAA receptors: structural composition and function 
GABAAR belongs to a superfamily ligand-gated ion channels able to mediate fast inhibitory 
transmission by gating Cl- ions through the cell membrane.  This receptor is a pentameric 
subunit-complex and consists of a hydrophilic extracellular N-terminal domain containing the 
Cys-loop, followed by four transmembrane sequences (M1–M4) which are arranged around a 
central pore. In mammals, there are 21 different subunits, including α1–6, β1–4, γ1–4, δ, ρ1–
3, θ, π, ε (Barnard et al., 1998; Whiting, 1999) which make the GABAAR very heterogeneous 
when compared to any other ligand-gated ion channel. The majority of GABAARs contain two 
α- and two β-subunits, and one γ-subunit variant (Fig. 12), with the α1β2γ2 combination 
representing the largest population of GABAAR, followed by α2β3γ2 and α3β3γ2. The γ2 
subunit can be substituted by γ1 or γ3 subunits or by δ, and possibly ε, subunits.  
Pharmacological studies of GABAAR allowed distinguishing between the various GABAAR 
subunits. Precisely, the α1-, α2-, α3-, and α5-subunit correspond to diazepam-sensitive 
receptors, whereas the α4- and α6-subunit are insensitive to diazepam (Benson et al., 1998; 
Wingrove et al., 2002). The GABAARs are discriminated further by their affinity to zolpidem, 
a selective allosteric modulator belonging to the nonbenzodiazepine of the imidazopyridine 
class (Mohler et al., 1996). Aside from this classical pharmacological characterization, 
neurosteroids, which are positive allosteric modulators of GABAARs (Lambert et al., 2001), 
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are most selective on receptors containing the δ-subunit (Wohlfarth et al., 2002). It is also 
important to note, that, depending on the α-subunit expressed, GABAARs may display 
differences in the kinetics of receptor deactivation (Hutcheon et al., 2000).  
GABAAR subunit molecular heterogeneity allows to generate two distinct forms of inhibitory 
transmission, phasic or tonic, depending on their postsynaptic or extrasynaptic localization, 
respectively (Farrant and Nusser, 2005; Belelli et al., 2009; Brickley and Mody, 2012). 
Importantly, these two major populations of GABAARs are molecularly distinct, with 
postsynaptic receptors containing mainly the α1, α2 and α3 subunits, along with β and γ2 
subunit, and extrasynaptic receptors composed by α4, α5 and α6 subunits, often combined with 
the δ subunit as an alternative to γ2 subunit. 
In the adult brain and spinal cord, the expression of GABAA receptor subunits exhibits a 
remarkable region- and cell-specificity, suggesting that individual subunits are necessary for 
the distinct neuronal circuits. The segregated distribution of α1- and α2-GABAARs is 
correlated with the differential kinetics of deactivation. Indeed, α1-GABAARs are responsible 
for the faster kinetics of deactivation, as opposed to α2-GABAARs (Brussaard et al., 1997; 
Hutcheon et al., 2000; Jüttner et al., 2001; Vicini et al., 2001). 
 
 
 
Fig. 12. GABAA receptor subunits: structure and composition.  
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Typical schematic representation of  GABAAR characterized by the 5 subunits composition usually 2α2β1γ, 
resulting in the formation of pore core channel designed for the Cl- and HCO3- ions transfer. The cartoon show 
also the spots used for binding different molecules such as GABA, neurosteroids, benzodiazepine, barbiturates, 
and picrotoxin, which are capable of modulating the GABAA-gated receptors (Meyer and Quenzer, 2013). 
GABAARs function is mainly characterized by their dependence on ion mechanisms, which 
provide the exchange of Cl- and HCO3- (Blaesse et al., 2009). Hence, the effects of GABAARs 
on the resting membrane potential, independently of their subunit composition, are determined 
by the action of K+/Cl- co-transporters and carbonic anhydrases. In fact, the increasing of 
KCC2, the main Cl- extrusion transporter, during the maturation of neurons leads to the switch 
from depolarising to hyperpolarising GABAAR actions (Ben-Ari, 2002). GABAAR-mediated 
transmission regulates multiple steps of neuronal development and maturation during 
ontogenesis and adult neurogenesis, including control of stem/precursor cell proliferation, cell 
fate decision, migration of precursor cells, survival of immature neurons, dendritic growth, and 
synaptogenesis (Platel et al., 2007; Dieni et al., 2013). 
4.2 GABAARs post-synaptic organization and plasticity  
In terms of molecular organisation, GABAergic post-synaptic sites consist of specific proteins 
which contribute to the trafficking and anchoring of GABAARs in a subtype-specific manner. 
More recent evidence proposes that GABAARs also clustered by gephyrin scaffold formation 
at postsynaptic sites (Sassoè-Pognetto et al., 2000; Saiepour et al., 2010). Gephyrin together 
with direct binding proteins, such as collybistin and NL2, represents the principal protein 
accountable for regulating GABAAR trafficking and GABAergic synapse formation (Luscher 
et al., 2011, Fritschy et al., 2012), α1, α2, and α3 subunits can interact directly with gephyrin 
via essential motifs located in their main intercellular loop, and hence be clustered 
postsynaptically (Tretter et al., 2008; Mukherjee et al., 2011; Kowalczyk et al., 2013). 
The formation and function of GABAergic synapses are due to the palmitoylation of the γ2 
subunit crucial for membrane anchoring of GABAARs. Consequently, multiple mechanisms 
such as phosphorylation of various GABAARs subunits, are responsible for regulating kinetic 
properties, or for stability, delivery, or further internalization of GABAARs (Jacob et al., 2008; 
Houston et al., 2009a, 2009b; Vithlani et al., 2011). Thus, gephyrin plays a key role as an 
anchor scaffold for protein kinase that regulates the efficiency of the inhibitory transmission.  
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Internalization of GABAARs is a key mechanism fundamental for the plasticity of synaptic 
transmission (Kittler and Moss, 2001; Kneussel, 2002). In fact, most synapses dynamically 
regulate synaptic receptor density by endocytosis, recycling, and degradation (Lin et al., 2000; 
Barnes et al., 2001).  
A major mechanism associated with recycling and degradation of membrane proteins is the 
clathrin-dependent endocytosis. This process is supported by the interaction between the 
clathrin adaptor protein (AP2) and the intracellular domains of β1-, β2-, and γ2-subunits, but 
not the α-subunits. In addition, Kittler et al., (2000) have shown that a large increase of mIPSCs 
amplitude occurs after blocking of clathrin-dependent endocytosis mechanism in neuron 
cultures.  
Neurotrophins, such as BDNF, play a role in excitatory synaptic plasticity by activation of 
TrkB signalling pathways. Likewise, BDNF produces a bi-phasic effect on the GABAAR-
mediated transmission via interference with the trafficking processes (Jovanovic et al.,2001). 
Particularly in the amygdala, BDNF causes the internalization of α1-GABAARs followed by a 
rapid degradation of gephyrin (Mou et al., 2013). In the hippocampus, on the contrary, an 
increased receptor expression on cell surface has been shown to be mediated by BDNF via the 
phosphorylation of γ2-subunit (Vithlani et al.,2013). In addition, other molecules, such as 
tyrosine kinase, ROS, and benzodiazepine are implicated in the regulation of trafficking and 
internalization of GABAARs (Ali and Olsen, 2001; Henneberger et al., 2002; Accardi et al., 
2014). 
4.3 The dynamic of intracellular chloride regulation  
In the brain and spinal cord, fast-synaptic inhibition is mediated by Cl- currents, supported by 
GABA and glycine receptors. Synaptic inhibition efficiency due to Cl- current flow, may 
emerge from the degree of GABA and glycine receptor activation or from the driving force of 
Cl- ions. The ionotropic GABA and glycine receptors associated channels are permeable to Cl- 
and the flow of the negatively charged chloride ions usually inhibits postsynaptic cells since 
the reversal potential for Cl- is more negative than the threshold for neuronal firing. In 
physiological conditions Cl- driving force is stable, but in the certain pathological conditions, 
the intracellular Cl- concentration ([Cl-]i) may be tuned by differential operations of membrane 
co-transporters. 
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 The individual concentrations of chloride ions outside and inside the cell define the chloride 
reversal potential (ECl
-), as described by the Nernst equation. ECl
- in the health, mature neurons, 
is approximate -85/-70 mV (Arosio et al., 2010). [Cl-]i is maintained at low concentrations 
(around 5 mM) that enable the influx of Cl- ions via opening of ionotropic GABA or glycine 
receptors (Payne et al., 2003; Ben-Ari et al., 2012; Kayla et al., 2014). This low concentration 
is maintained by the KCC2 co-transporter which extrudes Cl- ions against its gradient. KCC2 
takes advantage of the electrochemical K+ gradient due to the sodium-potassium ATPase, 
which is energy dependent (Fig. 13). Conversely, another co-transporter, named NKCC1, is 
essential for internalizing Cl- ions in the neurons. Particularly, NKCC1 allows Na+, K+, and Cl- 
transition inside the cell, using the same process of KCC2, thus exploiting the Na+/K+ ATPase.   
 
Fig. 13. Schematic Cl-/HCO3- regulation.  
Cl-/HCO3- flux through GABA/glycine receptors inside or outside the cell. Mechanisms associated with the 
cotransporters NKCC1/KCC2 important for the correct balance of the ion equilibrium. In addition, the energetic 
role carried out by Na+/K+ ATPase exploited by both cotransporters (Doyon et al., 2016). 
In immature neurons, the expression of KCC2 is low and KCC1 govern the Cl- membrane-
transport, generating typically a high (around 30 mM) [Cl-]i, fundamental for expressing 
depolarizing  GABAAR mediated responses (Achilles et al., 2007; Fig. 14).  
The expression profile of KCC2 mRNA is correlated with the sequential maturation of neurons 
(Li et al., 2002; Wang et al., 2002b; Stein et al., 2004). Generally, the ontogeny of KCC2 
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mRNA in mouse is similar to rat, with the singular difference concerning delays of 2 days in 
rat embryos (Li et al., 2002).   
Mouse spinal cord and brainstem show the earliest development of Cl- homeostasis. Expression 
of KCC2 mRNA starts at E10.5 while the KCC2 transcripts are found in the ventral motor as 
early as E12.5 (Hübner et al., 2001) and in sensory nuclei at later stages, E15.5  (Stein et al., 
2004). In mouse embryonic spinal cord, both KCC2 and NKCC1 are expressed and functional 
early in development (E11.5–E13.5), when GABAAR activation mediates excitatory responses 
(Delpy et al., 2008). After E15.5, NKCC1 progressively reduces its activity in motor neurons 
while KCC2 increases its function and provides more negative ECl
-, responsible of the 
inhibitory role of GABA and glycine receptor activation in the majority of spinal neurons at 
E17.5 (Branchereau et al., 2002). This switch corresponds to the transition phase in which the 
locomotor networks start to generate alternating flexor and extensor motor activities as well as 
the network expression of left-right alternation, indicating the presence of functional network 
inhibition (Delpy et al., 2008).  
4.4 Chloride regulation in CNS disorders  
Several pathological disorders in the CNS involve alterations in GABAergic synaptic 
signalling, affecting the physiological Cl- ion fluxes. These alterations may include (1) 
mutations in the GABAAR subunits composition and (2) dis-regulation in the NKCC1/KCC2 
balance (Lewis et al., 2005; Bavelier et al., 2010; Ben-Ari et al., 2012; Kaila et al., 2014).  
GABAAR mutations specifically of α, β3, γ2, and δ subunit are commonly correlated with 
various idiopathic epilepsies syndrome. In particular, the majority of this mutation is 
implicated in altering the orderly processes of trafficking and clustering (Bouthour et al., 
2012).  
GABAergic transmission also regulates neuronal plasticity by controlling the inhibitory-
excitatory balance in neuronal networks and is key in regulating the proper development of the 
CNS  
Potential dysfunctions of GABAAR are also implicated in a range of diseases which might be 
treated with benzodiazepine site ligands. This is the case of pathologies concerning the 
neuropathic pain. In fact, the anti-hyperalgesic effects mediated by certain benzodiazepine site 
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ligands take place via stimulation of α2-GABAAR in the spinal cord dorsal horn (Paul et al., 
2013).  
Alterations in the maturation of NKCC1/KCC2 balance during development have been 
correlated to various diseases, from childhood epilepsy to autism spectrum disorders (Ben-Ari 
et al., 2012; Kaila et al., 2014). In particular, mutations in the KCC2 gene have been associated 
with a partial or complete loss of chloride extrusion, which result in several modifications of 
the neuronal network activity (Stödberg et al., 2015; Fig. 14). 
 
Fig. 14. NKCC1/KCC2 expression during neuronal development and diseases. 
Divergent expression of NKCC1/KCC2 co-transporters in immature and adult neurons, which drive the [Cl-]i  
important for the excitatory-inhibitory GABAergic transmission. In the mature neurons, physiological conditions 
are characterized by high KCC2 and low KCC1 expression, which maintain low [Cl-]i. In contrast, during disease 
the NKCC1/KCC2 expression reflexes the same profile exhibit by early embryonic neuron, contributing to a 
GABAAR-mediated excitatory response (Ben-Ari, 2017).   
A similar loss of function of KCC2 has been reported in spinal cord dorsal horn, which 
therefore interferes with the sensory signalling associated with neuropathic pain pathologies 
(Doyon et al., 2013; Prescott, 2015). Many studies have shown that BDNF signalling via TrkB 
receptors is responsible for the KCC2 down-regulation. In fact, in experiments conducted on 
chronic pain models, BDNF appears to arise from microglia (Ferrini and De Koninck, 2013). 
Intriguingly, impaired Cl- homeostasis is also present in various pathological conditions of the 
brain and spinal cord, such as injury, neuroinflammation, and stress.  
Since a wide range of diseases are associated with Cl- dis-regulation, responsible for the failure 
of GABAA-mediated inhibitory transmission, several strategies have been developing in order 
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to restore the physiological low [Cl-]i  inside the neurons. One of these strategies is 
characterized by taking advantages of positive allosteric modulators, able to enhance the 
GABAAR (Knabl et al., 2008). Given that, the GABAAR allows the transition of both Cl
- and 
HCO3
- ions reducing the inward currents generated by HCO3
- efflux representing an alternative 
strategy to restore inhibition (Prescott, 2015).  
In addition, emerging tools to re-establish the normal ion homeostasis provide the use of 
pharmacological drugs that act on NKCC1. In particular, bumetanide a powerful blocker of 
NKCC1 has been revealed potentially useful to treat some developmental seizure-prone 
conditions, as well as reducing the severity of autism symptoms (Dzhala et al., 2005; 
Lemonnier et al., 2012). New strategies focused on the excess of KCC2, which might lead to 
a huge extracellular K+ accumulation, ultimately increasing the network excitability (Doyon et 
al., 2011; Krishnan and Bazhenov, 2011).  
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Aims of the thesis 
The principal aim of my thesis was to investigate the mechanisms underlying 
neuroinflammation which are able to interfere with the synaptic transmission. Since several 
neurodegenerative disorders involving spinal cord circuits are frequently accompanied by an 
inflammatory profile, the consequences of which result in neuronal defects, I focused my 
attention on a specific area of the SNC, the ventral spinal cord. For these reasons, my goal was 
to understand the key role of inflammation and resident cells in affecting the regular spinal 
pre-motor networks.      
I used a combination of two distinct elements to integrate both inflammation and spinal 
circuits: 
1. the organotypic spinal cultures obtained from mice embryos which represent an 
excellent model well characterized in our laboratory; 
2. a specific cytokines cocktail composed by TNF-α, IL-1β, and GM-CSF whose are 
reported to be highly concentrated in blood and CSF from MS patients and EAE 
model. 
In the first part of my work, by using the patch clamp voltage-mode technique I recorded the 
synaptic activity from visually identified interneurons located in the pre-motor microcircuits. 
In particular, I addressed my study in understanding the effect of CKs, and later LPS, on 
GABAA receptor-mediated currents. In doing so I also monitored the astrocytes and microglia 
responses under inflammatory stress conditions by immunohistological methods. 
In the second part of my work, I assessed more specifically the mechanisms involved in the 
alteration brought about by CKs of GABAA receptor-mediated currents, dissecting 
experimentally the following potential mechanisms: 
1. disequilibrium in the intracellular chloride homeostasis associated with alterations in 
the chloride co-transporters (NKCC1 and KCC2); 
2. variation in the α-subunit GABAAR composition due to exchange mechanisms 
between membrane and cytoplasm. 
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Abstract
Multiple sclerosis is characterized by tissue atrophy involving the brain and the spinal cord, where reactive inflammation
contributes to the neurodegenerative processes. Recently, the presence of synapse alterations induced by the
inflammatory responses was suggested by experimental and clinical observations, in experimental autoimmune
encephalomyelitis mouse model and in patients, respectively. Further knowledge on the interplay between
pro-inflammatory agents, neuroglia and synaptic dysfunction is crucial to the design of unconventional protective
molecules. Here we report the effects, on spinal cord circuits, of a cytokine cocktail that partly mimics the signature of T
lymphocytes sub population Th1. In embryonic mouse spinal organ-cultures, containing neuronal cells and neuroglia,
cytokines induced inflammatory responses accompanied by a significant increase in spontaneous synaptic activity. We
suggest that cytokines specifically altered signal integration in spinal networks by speeding the decay of GABAA
responses. This hypothesis is supported by the finding that synapse protection by a non-peptidic NGF mimetic
molecule prevented both the changes in the time course of GABA events and in network activity that were left
unchanged by the cytokine production from astrocytes and microglia present in the cultured tissue. In conclusion, we
developed an important tool for the study of synaptic alterations induced by inflammation, that takes into account the
role of neuronal and not neuronal resident cells.
Keywords: Organotypic spinal slices, Network activity, Cytokines, Neuroinflammation, Neuroprotection, NGF-mimetic
Introduction
Inflammatory mechanisms have been closely linked to the
pathogenesis of heterogeneous diseases of the Central
Nervous System (CNS), including multiple sclerosis (MS),
Alzheimer’s disease (AD), amyotrophic lateral sclerosis
(ALS) and Parkinson’s disease (PD) [1, 2]. In these patholo-
gies, inflammatory cytokines (CKs) can be either delivered
by activated microglia and astrocytes (CNS resident cells)
or by peripheral immune cells able to infiltrate the CNS
parenchyma (lymphocytes, neutrophils and mast cells).
CKs release affects neurons and synapses, contributing to
gray matter pathology. In experimental multiple sclerosis
the harmful action of microglia on synaptic activity is
mediated by tumor-necrosis factor-alfa (TNF-α) and
interleukin-1beta (IL-1β), and pro-inflammatory condi-
tions in general have been reported to tune post-synaptic
NMDA and AMPA glutamate receptors, enhancing excita-
tory transmission and inhibiting the GABAergic one [3–5].
These observations have led to the awareness that multiple
sclerosis pathophysiology, traditionally viewed as a genuine
white matter autoimmune disorder with only secondary
neurodegenerative components [6], involves diffuse synap-
tic dysfunction and loss, i.e. synaptopathy, that concur-
rently with demyelination contributes to grey matter
atrophy. Inflammatory-dependent synaptopathy, reviewed
by Mandolesi et al. (2015), has been detected in MS
patients, representing a novel and promising target for
future therapies [7].
Nerve growth factor (NGF), extensively studied as
neuro-protector agent in neurodegenerative diseases [8], is
involved in neuronal survival and reparative processes.
NGF has been reported to confer CNS protection in
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experimental autoimmune encephalomyelitis (EAE) [9].
Recently, Xu et al. (2016) described the neuroprotective ef-
fects of a molecule (T-006) that mimic NGF activities and
potentiates NGF-protection against glutamate-induced
excitotoxicity [10]. In accordance to these strategies, the
strongest rationale behind mesenchymal stem cell (MSC)
transplantation as an effective therapeutic approach in MS,
AD, PD and ALS, resides also in MSCs ability to secrete
neurotrophic factors, preventing neuronal damage induced
by the inflammatory insult [11]. In the development of
novel therapies, the design of trophic molecules able to
cross the blood brain barrier (BBB) and thus to directly
target neurons, shielding them from synaptic alterations, is
a timely placed issue.
Mechanistic studies of the interplay between the release
of CKs, the activation of microglia, the emergence of
synaptic dysfunction and the role of novel protective
molecules, may require sophisticated in vitro models
tested in the laboratory to investigate CNS responses at
synaptic resolution.
Organotypic slice cultures developed from the embry-
onic mouse spinal cord represent a complex in vitro
model where sensory-motor cytoarchitecture, synaptic
properties and spinal cord resident cells are retained in a
3D–fashion [12, 13]. By the use of this model, we have
recently shown that in the SOD1G93A mouse, a genetic
ALS model, spinal synapses retain greater GABA and
glycine co-release than in the wild types and these
changes influenced synaptic integration [14].
Here, we further exploit organotypic cultures from the
embryonic mouse spinal cord to monitor the emergence
of synaptopathy in pre-motor circuits following CKs
transient exposure, and to test the neuroprotective
efficacy of NGF-mimetic molecule MT2 [15].
We monitored synaptic activity by patch-clamp record-
ing of visually identified ventral interneurons. Spinal
cultured tissue exposed to a cocktail of pro-inflammatory
CKs displayed a significant increase in spontaneous synap-
tic activity characterized by a speeding up of the decay
phase of GABAergic inhibitory currents, that may affect
temporal precision at post-synaptic site and synaptic
control of network excitability. These changes were accom-
panied by significant production of cytokines and chemo-
kines, astrogliosis and microglia activation. Although these
inflammatory features were untouched by MT2 applica-
tions, this drug reverted all synaptic changes, suggesting
the need of specific neuro-protective strategies during
chronic inflammation in the CNS.
Results
Organotypic spinal cord cultures express TrkA and TrkB
receptors
Organotypic spinal slices represent a biological model use-
ful for studying the dynamics of intra-segmental processes
that evidently rely on resident neuroglial cells, propriosp-
inal neurons and circuits [12–14]. To investigate the
impact of inflammation on spinal synaptic networks we
used co-cultured mouse DRG and spinal cord explants
after 2 weeks of in vitro growth (Fig. 1a). These cultures
contain heterogeneous cell populations belonging to the
neuronal and neuroglial phenotypes [12], including
GFAP-positive astrocytes and Iba1-positive microglia
(Fig. 1b). We exploited this model to evaluate the NGF-
mimetic molecule MT2 ability to prevent synaptic modu-
lation brought about by neuroinflammation, the latter
induced by incubating (for 4 and 6 h) the tissue with pro-
inflammatory CKs (TNF-α, IL-1β and GM-CSF, 10 ng/
mL) [16]. Since MT2 is a ligand of TrkA and TrkB recep-
tors, we first checked the expression of these receptors in
the cultured slices. Figure 1c shows the western blot
analysis obtained under basal conditions and upon CK
stress in the presence or in the absence of MT2 (10 μM).
We found that both receptors are expressed by organoty-
pic cultures, and the levels of expression were comparable
in all the experimental conditions. By immunofluores-
cence labeling (Fig. 1d) we observed that TrkA and TrkB
are mainly expressed by DRG neurons and with TrkB, in
part, by astrocytes (Fig. 1e).
NGF-mimetic MT2 counteracts CKs induced increase in
synaptic activity in organotypic slices
We triggered the neuro-inflammatory stress by incubating
organotypic cultures with a cocktail of CKs. To directly
assess the presence of changes at the level of spinal
network activity we patch clamped visually identified ven-
tral interneurons and compared, under voltage clamp
mode, the emergence of heterogeneous spontaneous post-
synaptic currents (sPSCs; Fig. 2a) between control (CTRL;
n = 48) and treated cultures (CKs4H and CKs6H; n = 32
and n = 34, respectively). Organotypic spinal slices display
prominent spontaneous electrical activity in the ventral,
premotor area [13, 14]. To enable a meaningful compari-
son of the shifts in communication dynamics in networks
exposed to CKs, we selected the 2 WIV stage, where
neurons are known to exhibit an intense synaptic activity
[13, 14]. In all culture groups, sPSCs were represented by
heterogeneous inward currents of variable amplitudes
(Fig. 2a and b). CKs treatments did not affect neuronal
passive membrane properties (see Methods), however both
CKs incubation protocols significantly increased the fre-
quency of sPSCs. The plot in Fig. 2c shows (small symbols)
data for six different culture series (between 5 and 8 cells
in CTRL and CK4H or CK6H for each series), and the dif-
ference in mean values, reported as larger symbols, is sta-
tistically significant (19.1 ± 12.7 Hz CTRL; 29.6 ± 10.0 Hz
CKs4H; 31.7 ± 14.7 Hz CKs6H; **P = 0.0048 CTRL vs
CKs4H and **P = 0.0002 vs CKs6H, two-way ANOVA).
This result is in agreement with previous works reporting
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the ability of pro-inflammatory CKs, such as TNF-α or IL-
1β, to enhance synaptic transmission in spinal cord acute
slices [17–19]. However, differently from other studies [20,
21], the neuroinflammatory milieu did not affect the
frequency and amplitude of miniature (recorded in the
presence of TTX, 1 μM), pharmacologically isolated (in
the presence of bicuculline 20 μM and strychnine 1 μM),
AMPA-glutamate receptor-mediated excitatory PSCs
(mEPSCs; CTRL n = 37, CKs4H n = 20, CKs6H n = 20;
Fig. 2d). mEPSCs are independent of network function and
should primarily help to localize observed changes in
synaptic transmission to pre- and/or post-synaptic level.
Our results suggest that CKs treatments were not affecting
network activity by tuning excitatory synapses at the
pre-synaptic level, increasing the probability of release or
the number of release sites, or at the post-synaptic one,
altering the properties of glutamate receptors [22].
In parallel, we tested the effects of MT2 applications
prior and during CKs 4H and 6H treatments (Fig. 2b).
MT2 did not affect the passive properties of CTRL spinal
neurons (see Methods) that exhibited a variable and slight,
although not significant (P = 0.3292), increase in sPSCs
frequency (24.5 ± 14.1 Hz CTRL +MT2, n = 43), as sum-
marized in the plot of Fig. 2c. In the presence of MT2,
Fig. 1 TrkA/B receptor expression in organotypic spinal cord cultures. a Low magnification immunofluorescence for SMI32 (green) of an organotypic
spinal cord slice cultured for 2 weeks. The arrow indicates the ventral fissure, localizing the ventral horns. Note the co-cultured DRGs (arrow heads).
Calibration bar 500 μm. b High magnification immunofluorescence labeling for microglia, astrocytes, and neurons, details of the ventral horn (left) or
DRG (right) are shown. Left) green: Iba1 (microglia); red: GFAP (astrocytes). Right) green: GFAP (astrocytes); magenta: SMI-32 (neurons). Calibration bar
20 μm. c Western blot analysis of Tropomyosin receptor kinases A and B (TrkA and TrkB) expression in organotypic cultures stimulated with a cocktail
of pro-inflammatory CKs (TNF-α, IL-1β and GM-CSF, 10 ng/ml each) for 4 or 6 h in the presence or in the absence of NGF-mimetic molecule
MT2 (10 μM). GAPDH was used as house-keeping gene. Each well of the electrophoresis gel was loaded with an equal amount of proteins
extracted from a pull of n = 5 organotypic slices. Note that TrkA and TrkB expression is not affected by treatments. This experiment is representative of
3 independent ones. d Immunofluorescence confocal and differential interference contrast (DIC) images for TrkA and TrkB expression in DRG neurons.
Green: TrkA (left panel), TrkB (right panel). Red: SMI-32. Yellow: merge. Calibration bar 50 μm. e Immunofluorescence confocal images for TrkB and
GFAP in the ventral horns. Green: TrkB; magenta: GFAP Calibration bar 20 μm
Medelin et al. Molecular Brain  (2018) 11:3 Page 3 of 14
CKs treatments at both 4H (n = 40) and 6H (n = 40) did
not further boost sPSCs frequency (26.8 ± 11.5 Hz CKs4H
+MT2; 26.6 ± 12.8 Hz CKs6H +MT2). MT2 ability to
control the increase in sPSCs frequency brought about by
CKs treatments is summarized in the inset of Fig. 2c,
where the frequency of synaptic currents is expressed as %
of each control.
mEPSCs frequency and amplitude were unchanged
when measured in the presence of MT2, with or without
CKs (see Additional file 1: Figure S1). These results sup-
port the hypothesis that MT2 prevented the increase in
network activity caused by the inflammation milieu,
apparently without targeting at the pre or post-synaptic
level the AMPA receptor mediated synapses.
In the next set of experiments we explored fast Cl− me-
diated synaptic transmission and, because of the relatively
low frequency of glycinergic events at this developmental
stage in culture [13], we compared CTRL (n = 16) vs CKs
treated GABAA receptor-mediated synaptic events
(IPSCs), recorded in the presence of CNQX (10 μM),
APV (25 μM) and strychnine (1 μM). Upon CKs treat-
ments at 4H (n = 13) and 6H (n = 11) IPSC frequency (4.6
± 3.0 Hz CTRL; 4.9 ± 2.3 Hz CKs4H; 4.7 ± 3.1 Hz CKs6H)
and amplitude (20.1 ± 8.9 pA CTRL; 20.7 ± 9.5 pA CKs4H;
Fig. 2 Pro-inflammatory CKs modulation of synaptic activity in organotypic spinal cord cultures is prevented by MT2. In (a) and (b) Spontaneous
PSCs (sPSCs) recorded from organotypic spinal cord ventral interneurons in control (CTRL) or after CKs treatments in the absence in (a) or in the
presence in (b) of MT2. Note that CKs ability to increase sPSCs occurrence is prevented by MT2 applications. c The plot summarizes the frequency
of sPSCs prior and after CKs incubation, note the significant increase in network activity, and the frequency of sPSCs prior and after CKs incubation in
the presence of MT2, note the absence of significant changes in network activity. Small symbols depict data for six different culture series (between 5
and 8 cells each); larger symbols report mean values. In the inset: the frequency of sPSCs is expressed in respect to each control group, note the
increase by 55.27% in CKs4H and by 65.94% in CKs6H. Virtually no increases were observed in MT2: 9.20% in CKs4H +MT2 and 8.63% in CKs6H +MT2.
d Box-plots summarize the mEPSC event frequency and amplitude values in control or after CKs treatments. Note that CKs applications did not affect
these parameters. See the Additional file 1: Figure S1 for mEPSCs in MT2 control and MT2 CKs-treated organotypic slices
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25.2 ± 13.6 pA CKs6H) were not changed by the
inflammatory conditions in control or in the presence of
MT2 (sample tracings in Fig. 3a and b; box plots in
Additional file 2: Figure S2; CTRL +MT2 n = 16, CK4H +
MT2 n = 14, CK6H +MT2 n = 18).
Superimposed IPSCs in Fig. 3a (right), show that their
decay time constant (τ) becomes progressively shorter
with CKs treatments. In Fig. 3c the box plot summarizes
the measured τ values (32.3 ± 7.8 ms CTRL; 24.3 ±
4.7 ms CKs4H; 21.8 ± 5.6 ms CKs6H; *P = 0.020 CTRL
vs CKs4H, **P = 0.0014 CTRL vs CKs6H, two-way
ANOVA; scaled IPSCs average are superimposed, top).
The absence of a significant correlation between IPSC
rise time vs decay time values (CTRL r = 0.3693; CKs4H
r = −0.1897; CKs6H r = 0.3419; CTRL +MT2 r = 0.3629;
CKs4H +MT2 r = 0.4652; CKs6H +MT2 r = 0.4420;
plots in Additional file 2: Figure S2) suggests that
differences in recording conditions, location of synapses
or electronic filtering are unlikely to have affected our
observations. We extend our characterization to the
properties of miniature IPSCs (mIPSCs; recorded in the
presence of TTX). The results in this group of cells
confirm that upon CKs treatments mIPSCs differ in
their decay kinetics (45.0 ± 8.6 ms CTRL; 31.2 ± 10.4 ms
CKs4H; 21.9 ± 2.1 ms CKs6H; *P = 0.024 CTRL vs
CKs6H, n = 4 for each of the three groups, one-way
ANOVA; Additional file 3: Figure S3) in a manner simi-
lar to that of spontaneous IPSCs. In the presence of
MT2, IPSCs show comparable τ in all CKs treatments,
as exemplified by the superimposed events in Fig. 3b.
The τ values are summarized in the box plot of Fig. 3c
(27.5 ± 7.7 ms CTRL +MT2, 27.8 ± 4.7 ms CKs4H +
MT2, 26.8 ± 7.2 ms CKs6H +MT2; scaled IPSCs average
are superimposed, bottom). The changes in GABAergic
Fig. 3 Pro-inflammatory CKs modulation of GABAA receptor-mediated event time course is prevented by MT2. Representative traces of IPSC recorded
from organotypic spinal slices prior and after CKs treatments in control (a) and in the presence of MT2 (b). Note that while CKs did not increase IPSC
frequency, they affected IPSC time course (superimposed tracings). c Box-plots summarize the decay time constant values in all conditions, in the insets
the scaled and superimposed average IPSC are depicted (control in black, CKs 4H in red and 6H in blue) in the absence or in the presence of MT2.
Note that in the presence of MT2 no changes in the IPSC time course were detected following CKs treatments. In the inset: the τ is expressed as % in
respect to each control group, note the reduction by 24.59% in CKs4H and by 32.48% in CKs6H. Virtually no decreases were observed in MT2: slight
increase by 1.12% in CKs4H +MT2 and slight reduction by 2.44% CKs6H +MT2. See the Additional file 2: Figure S2 for GABAergic PSCs in the absence
or in the presence of MT2
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τ induced by CKs treatments are summarized in the
inset of Fig. 3c, reported as % of changes in respect to
each control.
We can hypothesize that the MT2 was actually able to
protect inhibitory synapses from pro-inflammatory
stimulation.
Both CKs and MT2 are not interfering with spinal neurons
excitability
To elucidate the neuronal mechanisms mediating neuro-
inflammatory increase in spinal activity, we addressed
whether CKs changed neuronal excitability. In current
clamp mode, recorded interneurones did not differ in
terms of resting membrane potential and firing thresh-
old (see Methods). Ventral interneurons in organotypic
slices have been identified on the basis of their discharge
patterns [13]. We identified four different classes of in-
terneurons on the basis of their firing pattern (Fig. 4a)
[13, 23–26]: ‘transient’ cells, that generated a single AP
only; ‘adapting’ cells, that discharged an early burst of
APs followed by adaptation; ‘irregular’ cells without
discernible pattern of AP discharge; ‘tonic’ cells, that
continuously fired APs without apparent accommoda-
tion. A fifth category (i.e. ‘delay’ cells, that generated APs
after a lag) [13] was rarely (< 4%) observed and thus was
not quantified in these series of experiments.
We used depolarizing current steps (0.1 and 0.2 nA
amplitude) [13] to induce the firing patterns. The
histograms depicted in Fig. 4b report the similar
distribution of discharge patterns in CTRL and CK4H
(CTRL 16% transient, 64% adapting, 10% irregular,
10% tonic, n = 31; CKs4H 24% transient, 44% adapt-
ing, 16% irregular, 16% tonic, n = 25) and such a
Fig. 4 Pro-inflammatory CKs and MT2 do not alter neuronal excitability in organotypic spinal slices. a Discharge patterns of ventral interneurons.
The 500 ms depolarizing current commands induced different discharge patterns that identified four cell categories: transient, adapting, irregular
and tonic. b Bar-charts illustrate the probability distribution (expressed as percentage of sampled population) of each cell type in the various conditions
in the absence (left) or in the presence (right) of MT2. c Box-plots illustrate the absence of changes in the frequency of spontaneous action potentials
in all conditions tested
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distribution was not affected by MT2 treatments
(CTRL +MT2 19% transient, 52% adapting, 16%
irregular, 13% tonic, n = 31; CKs4H +MT2 14% transi-
ent, 53% adapting, 11% irregular, 22% tonic, n = 36).
The only different value observed was the virtual
absence in CKs6H of transient firing cells, on the
contrary well represented in CKs6H +MT2 (CKs6H
0% transient, 62% adapting, 11% irregular, 27% tonic,
n = 26; CKs6H +MT2 22% transient, 59% adapting,
3% irregular, 16% tonic, n = 37).
The box plots in Fig. 4c quantify the frequency of
spontaneous APs, and also in this case no differences
were detected among CTRL and CKs treated (CTRL
0.7 ± 0.8 Hz, n = 14; CKs4H 0.9 ± 0.8 Hz, n = 14;
CKs6H 1.0 ± 1.1 Hz, n = 12) or CTRL +MT2 and CKs
+MT2 (CTRL +MT2 1.3 ± 0.9 Hz, n = 14; CKs4H +
MT2 0.8 ± 0.8 Hz, n = 18; CKs6H +MT2 1.0 ± 1.0 Hz,
n = 13).
These results suggest that cell excitability was not af-
fected by CKs or MT2.
Inflammatory stress modifies cytokine and chemokine
production and induces astrogliosis
We evaluated the production of cytokines and chemo-
kines by organotypic spinal cord slices in response to
pro-inflammatory stress. The summarizing plots of
Fig. 5a show that the exposure to Th1 cytokine cock-
tail significantly increases the release of IL6 and IL10,
key players in regulating inflammation, as well as the
release of CXCL1, CXCL2 and CCL2, chemokines
implicated in the recruitment of innate immune cells
(*0.01 < P < 0.05; **0.001 < P < 0.01; ***P < 0.001; one-
way ANOVA). CXCL10, a T cell chemoattractant, is
not affected by these treatments. MT2, independently
on the inflammatory stimulation, does not exert any
effect in the release of any analyzed soluble factor. As
expected, the altered cytokine profile induced by
pro-inflammatory stress is accompanied by marked
astrogliosis and microglia activation, qualitatively
illustrated in the example of Fig. 5b (compare with
Fig. 1b).
Fig. 5 Effects of pro-inflammatory stress on soluble factor production and on astro/microglia morphology in organotypic spinal slices. a Production of
cytokines (IL6; IL10) and chemokines (CXCL1; CXCL2; CCL2; CXCL10) determined by Milliplex assay in organotypic culture supernatants after stimulation
with the pro-inflammatory cytokine cocktail (CKs) for 4 or 6 h in the presence or absence of MT2. Column graphs report mean values ± SEM of 25
independent experiments. The pro-inflammatory stimulus significantly increases the release of IL6, IL10, CXCL1, CXCL2 and CCL2 compared to control
(first column), both after 4 and 6 h of treatment. MT2 treatment did not alter the soluble factor production. b Immune fluorescence staining
for astrocytes (GFAP, green) and microglia (CD68, red). The pro-inflammatory stress (CKs) induces astrocyte spreading and microglia activation,
as indicated by the amoeboid shape. MT2 treatment did not affect these cellular patterns. The pictures show one field representative of 5 randomly
analyzed ones (one experiment representative of 5 independent ones). Calibration bar 20 μm
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MT2 modulates p38 MAPK activation induced by
cytokine stress
It is generally accepted that many highly conserved
serine/threonine mitogen-activated protein kinases
(MAPK), including p38 MAPK, are activated in response
by environmental and cellular stresses including CKs
[15]. We investigated the interplay between MT2 treat-
ment and p38 MAPK activation in organotypic slices
undergoing pro-inflammatory cytokines incubation.
Fig. 6a shows the result of western blot analysis with
specific antibody to phospho-p38 MAPK performed in
lysates of organotypic slices subjected to CKs stimuli.
The data show a de-phosphorylation of p38 MAPK in
MT2 treated slices. To better understand the modula-
tion of p38 MAPK activation elicited by MT2, we tested
whether MKP-1, a phosphatase highly specific for p38
MAPK and also for JNK, could have a role in this set-
ting. Figure 6b shows that, at 6H CKs treatment, MT2
caused an increase in MKP-1 expression. Taken together
these data suggest that MT2 has trophic effects on slices
undergoing metabolic derangement induced by pro-
inflammatory cytokines.
Discussion
The dogma of the CNS immune-privilege is progressively
weakening. In the last decade, an increasing amount of re-
sults suggested that, notwithstanding its being surrounded
by the BBB, the CNS is a highly immunological active
organ, characterized by complex immune cell activation
[27] resulting in beneficial (protective) as well as harmful
(degenerative) responses [28].
Inflammation, synaptic transmission and neuronal
damage are ultimately linked [7]. In this work we have
investigated pro-inflammatory CKs effects in spinal mi-
crocircuits developed in organotypic cultures containing
microglia, astrocytes and neurons, focusing on synaptic
activity and measuring soluble factor production. Last,
we exploited this model to demonstrate the synaptic
protective role of neurotrophins by treating the culture
with a non-peptidic mimetic molecule (MT2) that binds
TrkA/B receptors.
We selected a CKs cocktail able to mimic an inflam-
matory reaction that spreads in CNS containing IL-1β,
well known determinant of neuropathy [3, 7], TNF-α,
that is ubiquitary present during Th1/Th17 mediated
inflammatory reactions, and GM-CSF, key cytokine
responsible of pro-inflammatory effects in the CNS of
MS animal models [29]. GM-CSF receptors are
expressed in microglia, therefore the use of this soluble
factor allows targeting resident microglial cells, present
within the organotypic spinal explanted tissue. Indeed,
one of our aims was that to address synaptic function
in CNS circuits in the presence of astrocytes and
microglia exposed to CKs. We used factors known to
be released in EAE and able to directly and indirectly
(via activation of resident cells) target neuronal func-
tions. We adopted relatively acute treatments, which
triggered inflammatory responses, without affecting neur-
onal membrane properties or inducing direct neurotox-
icity, yet still able to alter synaptic transmission. This
protocol has allowed unmasking subtle early changes in
GABAergic synaptic currents, a significant player in the
excitation/inhibition balance of pre-motor outputs.
Fig. 6 Effects of MT2 on MAP Kinase pathway in organotypic spinal slices. Organotypic cultures were stimulated with pro-inflammatory CKs cocktail
for 4 or 6 h, in the presence or in the absence of MT2. a Slices lysates were blotted with rabbit anti-P-p38 and mouse anti-Tubulin as loading control.
Bar-charts represent the data of densitometric analysis and are expressed as the ratio between phospho-p38 and Tubulin proteins. b Slices lysates were
blotted with rabbit anti-MkP-1 and rabbit anti-ERK 1/2 as loading control. The bar-charts represent the data of densitometric analysis and are expressed
as the ratio between MKP-1 and ERK 1/2 proteins
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Pro-inflammatory CKs tune the excitability of organotypic
pre-motor circuit
In organotypic spinal tissue we confirmed the presence of
heterogeneous neuroglial cells after 2 weeks of in vitro
growth [9], and we further documented the expression
and cell-localization of TrkA/B receptors (see below). In
the present study, we have used a CKs cocktail and set a
tissue exposure protocol to these agents that did not alter
TrkA/B receptor expression, however such agents induced
a reliable release of cytokines and chemokines, mostly due
to the local generation and delivery of inflammatory
factors. In fact, upon CKs stimulus, we reported clear
inflammatory tissue reactivity expressed as IL6 and mono-
cytes recall-chemokines release, likely requiring the
involvement of the heterogeneous cell types present in the
slice culture. Our experimental model is ideally suited to
dissect spinal resident cells ability in modulating local
synapses, in the absence of any contributions from the
peripheral infiltrating cells, this mimics early phases of
multiple sclerosis where immune cells in brain perivascu-
lar spaces activate and produce inflammatory CKs that
easily diffuse before cells enter the CNS [30]. In particular,
CNS cultured explants allow investigating complex synap-
tic networks preserving the basic cytoarchitecture of the
original CNS area [31], but, differently from acute slices,
long term culturing allows the complete recovery from
the altered metabolic state caused by the tissue dissection
and promotes the effective clearance from the tissue
debris, due to the slicing procedure [32, 33].
We recorded from interneurons to assess how the
pro-inflammatory stress may regulate the ventral (pre-
motor) [14] circuit activity, and this was done within a
time-frame where the inflammatory pathological process
did not progress to the extent of excitotoxicity. The lack
of clear cell damage was supported by the absence of
changes in the values of resting membrane potential, in-
put resistance, cell capacitance and AP threshold in the
treated neurons in respect to control ones [34–36].
The present data show that, after 4 and 6 h CKs treat-
ments, the frequency of sPSCs was increased. An in-
creased synaptic transmission is a described feature of
pro-inflammatory stress in neural circuits, reported form
ex-vivo CNS slices isolated from EAE mouse models or
from healthy slices exposed to cerebrospinal fluid from
multiple sclerosis patients [3, 5, 37] as well as from acute
spinal cord slices transiently exposed to various pro-
inflammatory molecules [17–19]. Such increases in
synaptic transmission have been attributed to the up-
regulation of the glutamatergic system [3, 5, 37], to the
down-regulation of inhibitory transmission [17, 18, 38]
or to altered cell excitability [19, 39]. In spinal cultured
slices we did not detect the signatures of any of these
mechanisms. To understand the reason for the observed
boost in spinal network activity, we examined the
miniature excitatory currents [22] that did not suggest
the presence of changes in pre-synaptic release probabil-
ity and in the number of synaptic contacts or in post-
synaptic receptor sensitivity in glutamatergic synapses
due to CKs exposure, we also excluded alterations in
single cell excitability. We equally ruled out variations in
the general distribution of firing patterns [13, 19] and in
the frequency or amplitude of IPSCs.
We focused our attention to the fast Cl−-mediated
neurotransmission due to GABAA receptor activation,
recently indicated as a specific CKs target in spinal cir-
cuits [17, 19, 39]. Intriguingly, we found that both IPSCs
and mIPSCs from 4 and 6 h CKs slices decayed faster
than those from controls, in the absence of any other
changes, including differences in release synchronization
[14]. This is, to our knowledge, the first time that such a
modulation of GABAergic activity is reported due to
pro-inflammatory CKs exposure. We did not further
investigate in the present work the mechanisms respon-
sible for the altered kinetic properties of GABAergic
receptors and therefore the IPSC time course, which can
involve differences in the intracellular chloride concen-
tration [40, 41] as well as changes in the receptor
subunit composition [42].
Regardless the mechanisms involved, our experimental
conditions unmasked a sophisticated and specific synaptic
regulation during inflammatory states that may contribute
to the increase pre-motor circuit excitability via network-
mediated mechanisms. In fact, the faster decaying
GABAergic PSCs will lead to weaker and shorter-lasting
inhibition, resulting in a reduction in charge transfer in
the range 28–35%, perhaps associated with increased
network activity. This hypothesis is in agreement with the
MT2 ability to control both the CK-mediated increase in
network activity and the reduction in IPSC decay. It is
tempting to speculate that the different CKs cocktail, the
duration of the exposure used here, longer than in the
previous studies on acute spinal slices [17, 19, 39], and, in
particular, the presence of resident cells, are all factors
ultimately responsible of this divergence from previous
results. In addition, when compared to acute slicing, the
presence of full metabolic recovery from dissection in
organ cultures, might also play a significant role.
Interestingly, in previous reports, in dissociated cultures
exposed to inflammatory cues [38], the involvement,
during chronic EAE phases, of perturbed GABAergic
transmission, was suggested together with the need of
alternative neuroprotective strategies.
MT2 protective effect on spinal organotypic cultures
With the aim to restore spinal network activity following
the neuroinflammatory treatment, we turned our atten-
tion to NGF. NGF is a well-known regulator of neuronal
differentiation and plasticity [43]. More recently, NGF
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has been associated to inflammation and autoimmune
diseases. NGF, via TrkA receptors, down-regulates in-
flammatory CKs production while inducing the release
of anti-inflammatory mediators [44]. Moreover, adminis-
tration of NGF in vivo in EAE animals delays the onset
of clinical symptoms and prevents the full development
of EAE lesions [45–48]. Despite these exciting reports,
the therapeutic use of neurotrophins is a daunting task,
due to their limited ability to diffuse in tissues [15]. There-
fore, the design of small molecules able to interact with neu-
rotrophins receptors is of great therapeutic interest. In our
cultures, TrkA is specifically expressed in DRG and other
neurons; on the other hand, we found TrkB expression also
in astrocytes. TrkB expression in cultured DRG was not
unexpected [49], reviewed in [50]; the finding of TrkB ex-
pression in astrocytes is, although surprising for cultured
tissue, reminiscent of the complexity of the CNS in vivo. In
fact, in the adult rodent spinal cord TrkB expression has
been described in reactive astrocytes [51–53]. We did not
detect TrkB in CD68+ microglia, present in our culture
mostly in amoeboid (activated) form after CKs treatments,
in agreement with a previous report on the spinal cord
[54–56]. Notwithstanding TrkB expression in the organoty-
pic GFAP-positive astrocytes, (probably the main source of
IL-6), the sole addition of MT2 did not modify CK profile
in the supernatants, neither directly nor by neuron medi-
ated immune modulation [57]. However, MT2 controlled
the CKs electrophysiological signature, namely the induced
increase in the sPSCs frequency and the modulation of
IPSC time course. To note, MT2 provoked a slight increase
in synaptic activity per se, although not significant, and one
could argue that in this manner the CKs potentiating effect
was simply occluded. Against this interpretation, we also re-
ported the efficacy of MT2 in preventing IPSC decay time
modulation. Previous observations [15] suggested the possi-
bility of relatively fast transduction events, after engaging
the tyrosine kinase receptors; such mechanisms may explain
the short time (no more than 4 h) needed in order to ob-
serve the MT2 counteracting effect on electrophysiological
alterations. We also reported a trend of decrease in p-p38
accompanied by an increase in MKP-1. These results are,
although preliminary, suggestive of such pathways involve-
ment in rescuing GABAergic PSCs.
In conclusion, we developed an important tool for the
study of spinal cord alterations induced by inflammation,
that takes into account the role of resident cells: neur-
onal and not neuronal populations, this tool allowed us
to test a potential therapeutic molecule.
Methods
Preparation of spinal cord organotypic cultures and
neuroinflammation treatments
Briefly, organotypic slice cultures of spinal cord and dorsal
root ganglia (DRG) were obtained from mouse embryos
(C57BL/6 J of either sex) at days 12–13 of gestation as
previously described [13, 14, 58, 59]. Pregnant mice were
sacrificed by CO2 overdose and fetuses delivered by cae-
sarean section. Isolated fetuses were decapitated and their
backs were isolated from low thoracic and high lumbar
regions and transversely sliced (275 μm) with a tissue
chopper. After dissecting the spinal cord slices from the
surrounding tissue, slices were embedded into a thick
matrix obtained by chicken plasma (Rockland) and throm-
bin (Sigma) clot. Slices were cultured in plastic tubes with
1 mL medium [14]. The tubes were kept in a roller drum
rotating 120 times per hour in an incubator at 37 °C in
the presence of humidified atmosphere, with 5% CO2. Ex-
periments were performed on spinal cultures at 2-weeks
in vitro (WIV). The day of the experiment, organotypic
spinal cord slices were incubated with standard medium
(Control, CTRL) or, for 4 or 6 h (4H and 6H), with a
cocktail of the following mouse recombinant cytokines:
TNF-α (R&D Systems, #210-TA/CF), IL-1β (R&D
Systems, #M15330), and granulocyte-macrophage colony-
stimulating factor (GM-CSF; R&D Systems, #P04141),
10 ng/mL each, in order to induce an inflammatory state
(Hanisch, 2002). CKs were removed after 4H and 6H,
prior to electrophysiological recordings. In sister cultures,
controls and the incubation with the CKs cocktail was
done in the presence or absence of MT2, a NGF mimetic
non-peptidic TrkA and TrkB ligand, kind gift from Mime-
Tech srl, Rome, Italy. MT2 (10 μM for 4H) was tested in
the same three conditions (CTRL, CKs4H and CKs6H; in
CKs6H condition, MT2 was added after the first 2H of
the CKs treatment).
Immunofluorescence and microscopy
Organotypic cultures were fixed in 4% formaldehyde (pre-
pared from fresh paraformaldehyde; Sigma) in PBS for 1 h
at room temperature (RT; 20–22 °C), washed in PBS and
incubated at RT for 1 h in blocking/permeabilizing solu-
tion consisting of 3% FBS and 3% BSA (Sigma) and 0.3%
Triton-X 100 (Sigma) in PBS. Then, slices were incubated
over night at 4 °C with a combination of the following
primary antibodies, diluted in blocking/permeabilizing
solution: mouse monoclonal anti-glial fibrillary acidic
protein, (GFAP; Sigma, #G3893, RRID:AB_477010, 1:200);
rabbit polyclonal anti-ionized calcium-binding adapter
molecule 1, (Iba1; Wako, #019–19,741, RRID:AB_839504,
1:400); rat monoclonal CD68 (Abcam, #ab53444, RRI-
D:AB_869007, 1:200), rabbit polyclonal against Tropomy-
osin receptor kinase A (TrkA), (Santa Cruz, #SC-14024,
RRID:AB_2298807, 1:200); rabbit monoclonal against
Tropomyosin receptor kinase B (TrkB), (Cell Signaling
Technologies, #4607S, RRID:AB_2155128 1:100); mouse
monoclonal anti-Neurofilament H Non-Phosphorylated
(SMI-32; EMD-Millipore, #NE1023, RRID:AB_2043449,
1:200). Subsequently slices were PBS-washed and
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incubated with secondary antibodies diluted in blocking/
permeabilizing solution for 2 h at room temperature (RT)
in the dark. The secondary antibodies we used were: Alexa
635 goat anti-mouse (Invitrogen, #A31574, RRI-
D:AB_2536184, 1:250); Alexa 488 goat anti-mouse (Invi-
trogen, #A11001, RRID:AB_2534069, 1:400); Alexa 546
goat anti-mouse (Invitrogen, #A11003, RRID:AB_141370,
1:400); Alexa 488 donkey anti-rabbit (Abcam, #ab150061,
RRID:AB_2571722, 1:300). Samples were PBS-washed and
mounted on glass slides with ProLong® Diamond Antifade
Mountant with DAPI (Thermo Fisher Scientific). Stained
samples were examined with 20× and 40× magnification
on a Laser Scanning Confocal Microscopy (LSM 5109
Meta, ZEISS); sections were acquired at different focal
planes every 1 μm. The image analyses were performed
using the ImageJ software (http://rsbweb.nih.gov/ij/).
Western blot analysis
Organotypic slices (n = 5 for each experimental condition)
were lysed with RIPA buffer (50mM Tris-HCl, pH 7.4;
150mM NaCl; 2 mM EDTA; 1mM NaF; 1 mM sodium
orthovanadate, 1% NP-40) in the presence of phosphatase
inhibitor cocktail 2 and 3, protease inhibitor cocktail
(Sigma Aldrich) and centrifuged at 12.000 r.p.m. for 15
min. 40 μg of total proteins were loaded into SDS-PAGE
and blotted onto nitrocellulose filters (GE Healthcare,
Fairfield, CT, USA). Membranes were stained with rabbit
anti-TrkA, anti-TrkB, anti-MKP-1, anti-ERK ½, anti-P-
p38 (Cell Signaling), mouse anti-GAPDH (Cell Signaling),
mouse anti-α-tubulin (Santa Cruz Biotechnology); all the
antibodies were used at 1:1000, final dilution. HRP-
coniugated anti-rabbit IgG (GE Healthcare) or HRP-
conjugated anti mouse IgG (Santa Cruz Biotechnology)
were used as secondary antibodies at 1:2000 final dilution.
The reactions were visualized by the ECL detection system
as recommended by the manufacturer (GE Healthcare).
Electrophysiological recordings
For patch clamp recordings (whole-cell) a coverslip with
the spinal culture was positioned in a recording cham-
ber, mounted on an inverted microscope (Nikon Eclipse
TE200 and Nikon Eclipse Ti-U), and superfused with a
standard saline solution containing (in mM): 152 NaCl,
4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose. The
pH was adjusted to 7.4 with NaOH (osmolarity
305 mOsm). Visually identified ventral interneurons
were patched with pipettes (4–7 MΩ) filled with a solu-
tion of the following composition (in mM): 120 K gluco-
nate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP.
The pH was adjusted to 7.3 with KOH (295 mOsm). All
recordings were performed at RT.
Under voltage clamp configuration, the voltage values
indicated are corrected for the liquid junction potential
(−14 mV) [14] if not otherwise indicated. Series
resistance values were < 10 MΩ enabling recordings of
synaptic currents without significant distortion, and
were not compensated for [13]. Recordings were
performed from ventrally located spinal interneurones
identified on the basis of previously reported criteria [13,
60, 61]. Electrophysiological responses were amplified
(EPC-7, HEKA; Multiclamp 700B, Axon Instruments),
sampled and digitized at 10 kHz with the pCLAMP
software (Axon Instruments) for offline analysis.
In voltage-clamp recordings, single spontaneous post-
synaptic currents (sPSCs) were detected by the use of
the AxoGraph X (Axograph Scientific) event detection
program [62] and by the Clampfit 10 software (pClamp
suite, Axon Instruments). On average, ≥ 400 events were
analysed from each cell in order to obtain mean kinetic
and amplitude parameters. From the average of these
events we measured the rise time defined as the 10–90%
time needed to reach the peak of the synaptic current,
the peak amplitude and the decay time constant
(expressed as τ) by fitting a mono-exponential function.
We detected no differences in membrane capacitance
(45 ± 21 pF CTRL, 46 ± 19 pF CKs4H, 48 ± 18 pF
CKs6H; n = 55, 41, 39, respectively; and 48 ± 21 pF
CTRL +MT2, 43 ± 16 pF CKs4H +MT2, 46 ± 24 pF
CKs6H +MT2; n = 53, 47, 47, respectively) and input
membrane resistance (417 ± 247 MΩ CTRL, 415 ± 328
MΩ CKs4H, 424 ± 404 MΩ CKs6H; and 400 ± 354 MΩ
CTRL +MT2, 430 ± 309 MΩ CKs4H +MT2, 407 ± 244
MΩ CKs6H +MT2) of ventral spinal interneurons
recorded in the different conditions. GABAergic post-
synaptic currents (IPSCs) were recorded at −84 mV
holding potential in the presence of CNQX (10 μM;
Sigma), strychnine (1 μM; Sigma) and APV (25 μM;
Sigma) and tetrodotoxin (TTX; 1 μM, Latoxan) was used
to isolate GABAA receptor-mediated miniature events
(mIPSCs). GABAA receptor-mediated PSCs were fully
blocked by the application of 10 μM SR-95531 (Sigma).
AMPA-glutamate receptor-mediated PSCs were recorded
at −70 mV holding potential in the presence of strychnine
(1 μM; Sigma) and bicuculline (10 μM; Sigma), and TTX
(1 μM, Latoxan) was used to isolate AMPA-glutamate
receptor-mediated miniature events (mEPSCs). AMPA-
glutamate receptor-mediated PSCs were fully blocked by
the application of 10 μM CNQX (Sigma).
During current clamp recordings, bridge balancing
was continuously monitored and adjusted [13]. Action
potentials (APs) were isolated off line by setting an
appropriate threshold (−34 mV). The fast (~ 3 ms dur-
ation) voltage transients that crossed this threshold were
identified as APs. The spontaneous firing frequency for
each neuron was calculated on a sample of at least
5 min of continuous recording at −74 mV resting mem-
brane potential. APs threshold was experimentally deter-
mined by depolarizing current steps [63].
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Induced AP discharge patterns were investigated by
delivering depolarizing current steps (500 ms duration)
of 0.1–0.2 nA amplitude while keeping the cells at
−74 mV resting potential with steady intracellular
current injection. We did not detect differences between
all the conditions tested in neither interneuron resting
membrane potential (−64 ± 9 mV CTRL, −65 ± 9 mV
CKs4H, −63 ± 12 mV CKs6H; n = 21, 16, 16, respectively;
and −66 ± 8 mV CTRL +MT2, −68 ± 6 mV CKs4H +
MT2, −64 ± 7 pF CKs6H +MT2; n = 24, 21, 22, respect-
ively), nor in the spike threshold (−53 ± 4 mV CTRL,
−54 ± 5 mV CKs4H, −53 ± 5 mV CKs6H; and −51 ±
5 mV CTRL +MT2, −53 ± 4 mV CKs4H +MT2, −52 ±
3 mV CKs6H +MT2). Electrophysiological data were ob-
tained from 20 different culture series.
Cytokines and chemokines measurement
IL6, IL10, CCL2, CXCL1, CXCL10 and CXCL2 concentra-
tions were measured in organotypic culture supernatants
by Milliplex assay (Merck Millipore, #MCYTOMAG-
70 k), using the Bio-Plex apparatus (Biorad), according to
the manufacturer’s recommendations.
Statistical analysis
All values from samples subjected to the same experimental
protocols were pooled together and results are presented as
mean ± S.D., if not otherwise indicated; n = number of neu-
rons. Two-way analysis of variance (two-way ANOVA) and
one-way ANOVA were used to determine significance
when multiple groups were compared. Statistical signifi-
cance was determined at P < 0.05.
Additional files
Additional file 1: Miniature excitatory PSCs were not affected by MT2
prior or after CKs treatments. The box plots summarize the mEPSCs
frequency (A) and amplitude (B) in control and CKs-treated organotypic
slices. (TIFF 294 kb)
Additional file 2: The frequency and amplitude of GABAergic PSCs were
not affected by CKs treatments in the absence of in the presence of MT2.
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and after CKs incubation in both the absence and the presence of MT2. (C)
The plots show the absence of linear correlation between the decay time
constant and rise time of IPSCs in all the conditions tested. (TIFF 777 kb)
Additional file 3: Miniature inhibitory PSCs were faster after CKs
treatments. Box-plots summarize the decay time constant values of
mIPSCs in all conditions (A). Note the speeding up of the event time
course following CKs treatments. (TIFF 89 kb)
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Neuroinflammation by Cytokines but not by LPS shapes GABAergic 
currents in mouse spinal cord explants culture. 
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Methods 
Organotypic spinal cord cultures, pro-inflammatory treatments, and pharmacology 
All experiments were performed in accordance with the EU guidelines (2010/63/UE) and 
Italian law (Decree 26/14) and were approved by the local authority veterinary service and by 
our institution (SISSA-ISAS) ethical committee. All efforts were made to minimize animal 
suffering and to reduce the number of animals used. Animals use was approved by the Italian 
Ministry of Health, in agreement with the EU Recommendation 2007/526/CE. 
Organotypic spinal cord slices and dorsal root ganglia (DRG) were obtained from mouse 
embryos (C57BL/6J) at E12-13 of gestation as previously described (Furlan et al., 2007; 
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Fabbro et al., 2012; Medelin et al., 2016; Usmani et al., 2016; Medelin et al., 2018). 
Experiments were performed on spinal cultures at 2 and 3 weeks in vitro (WIV). 
Stimulation of neuroinflammation was achieved by incubating the cultured slices, 4 and 6 hour 
(4H and 6H), with the following pro-inflammatory molecules: i. a cocktail of the mouse 
recombinant cytokines (CKs; 10 ng/mL each; Medelin et al., 2018) tumour necrosis factor-α 
(TNF-α; R&D Systems), interleukin-1β (IL-1β; R&D Systems), granulocyte macrophage-
colony stimulating factor (GM-CSF; R&D Systems);]. ii. lipopolysaccharide (LPS; Sigma) at 
1 μg/mL. For LPS we also tested a longer incubation timepoint (24H). Control cultures 
underwent the same medium changes, but without CKs or LPS. After incubations (4H, 6H and 
24H) CKs and LPS were washed out prior to electrophysiological recordings. 
Bumetanide (Sigma) was used to block the Na+/K+/Cl- co-transporter (NKCC1), and to inhibit 
chloride uptake. To decrease the cytoplasmic chloride concentration, slices were incubated for 
24 hours at 37° C with bumetanide at 10 μM (BUM24H) and then the CKs cocktail was added 
for 4 hours (BUM24H + CKs4H). 
Immunofluorescence, imaging, and analysis 
Organotypic cultures were fixed with 4% formaldehyde (prepared from fresh 
paraformaldehyde, Sigma) in phosphate buffer solution (PBS 1, Sigma) for 1 hour at room 
temperature (RT; 20 ÷ 22 °C) and washed in PBS. Free aldehyde groups were quenched in 0.1 
M glycine in PBS for 10 minutes. Slices were permeabilized and blocked in PBS 1, 5 % FBS 
(Sigma), 1 % BSA (Sigma), and 0.3 % Triton-X 100 (Sigma) at RT for 1 hour and then 
incubated overnight at 4 °C with anti-GFAP (mouse monoclonal, 1:400, Sigma), anti-Iba1 
(rabbit polyclonal, 1:200, Wako), anti-SMI32 (mouse monoclonal, 1:200, EMD-Millipore), 
and anti-MAP2 (mouse monoclonal, 1:200, Sigma) primary antibodies. 
For β-tubulin III and GAD65/67 co-immuno-labelling, fixed samples were quenched with Na 
(meta)periodate 2.3% in deionized water for 5 min and Na borohydride 1% in TRIS 0.1M for 
10 minutes. Slices were blocked in free-floating with PBS 1, 10 % FBS (Sigma), 1 % BSA 
(Sigma), 1 % fish gelatin and 0.3 % Triton-X 100 (Sigma) at RT for 1 hour and then incubated 
overnight at 4 °C with anti-β-tubulin III primary antibody (mouse monoclonal; 1:500, Sigma) 
and anti-GAD65/67 (rabbit polyclonal; 1:500, ABCAM). 
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Subsequently, the slices were PBS-washed and incubated with secondary antibodies diluted in 
blocking solution for 2h at RT in the dark. The secondary antibodies were: Alexa 488 goat 
anti-mouse (1:500, Invitrogen); Alexa 488 goat anti-rabbit (1:500, Invitrogen); Alexa 594 goat 
anti-mouse (1:500, Invitrogen); Alexa 594 goat anti-rabbit (1:500, Invitrogen); DAPI (Thermo 
Fisher Scientific). Samples were mounted on glass coverslips using Vectashield mounting 
medium (Vector Laboratories). 
Images were acquired using Nikon C2 Confocal microscopes with Ar/Kr, He/NE, and UV laser 
with 20 , 40  or 63  oil objectives (1.4 n.a.) using oil mounting medium (1.515 refractive 
index). Confocal sections were acquired every 0.5 μm up to a total Z-stack thickness of 5 μm. 
For each condition, we performed n = 3 ÷ 6 independent cultures, from each culture series we 
used 3 ÷ 4 slices, where 3 ÷ 8 fields were randomly acquired. Offline analysis of the image Z-
stack was performed using the open source image-processing package FIJI (http://fiji.sc/Fiji).  
Analysis of microglia morphology was performed by creating a camera lucida with Photoshop 
(PhotoshopCS6Portable) and then processed by NeurphologyJ FIJI plug-in (Ho et al., 2011).  
Quantification of GAD65/67 immunoreactivity was performed measuring the intensity of 
fluorescence, the voxel count and the number of GAD65/67 clusters using the Volocity3D 
Image Analysis Software. Clusters were determined after thresholding of images.  Thresholds 
were determined using the ‘voxel spy’ facility of the software and chosen such that all 
recognizable punctuate structures were included into the analysis (size higher than 0.03 μm3 
and separate touching objects of 0.5 μm3). 
Electrophysiological recordings and data analysis 
For patch clamp recordings (whole-cell, voltage clamp mode), a coverslip with the spinal 
culture  (2 and 3 WIV) was positioned in a recording chamber, mounted on an inverted 
microscope (Nikon Eclipse TE200) and superfused with a standard saline solution containing 
(mM): 152 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose, the pH was adjusted to 
7.4 by NaOH (305 mOsm). Patch pipettes were pulled from borosilicate glass capillaries (4 ÷ 
7 Mand filled with intracellular solution containing (mM): 120 K gluconate, 20 KCl, 10 
HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP. The pH was adjusted to 7.3 with KOH (295 mOsm). 
All electrophysiological recordings were performed at RT. 
 
 
66 
The reported voltage values are corrected for the liquid junction potential (14 mV) (Medelin 
et al., 2016). Electrophysiological responses were amplified (EPC-7, HEKA), sampled and 
digitized at 10 kHz with the pCLAMP software (Axon Instruments) for offline analysis. The 
value of series resistance was <10 MΩ enabling recordings of synaptic currents without 
significant distortion and thus was not compensated for (Furlan et al., 2007; Medelin et al., 
2016). Recordings were performed from ventrally located spinal interneurons visually 
identified based on previously reported criteria (Galante et al., 2000). Spontaneous 
postsynaptic currents (PSCs) were recorded at 70 mV holding potential by the Clampfit 10 
software (pClamp suite, Axon Instruments). On average, ≥ 300 events were analyzed from 
each cell in order to obtain mean kinetic and amplitude parameters. From the average of these 
events, we measured the rise time defined as the 10 – 90 % time needed to reach the peak of 
the synaptic current, the peak amplitude and the decay time constant (τ) that was obtained by 
fitting a mono-exponential function. 
We compared the passive membrane properties among Control, CKs- and LPS-treated spinal 
interneurons. We detected no differences in capacitance (51 ± 31 pF Control; 43 ± 23 pF CKs 
4H; 43 ± 21 pF CKs 6H; n= 62, 47, 54 respectively; 55 ± 23 pF Control; 44 ± 18 pF LPS 4H; 
48 ± 22 pF LPS 6H; n= 35, 38, 34, respectively) and input resistance (470 ± 395 MΩ Control; 
587 ± 537 MΩ CKs 4H; 481 ± 414 MΩ CKs 6H; 430 ± 323 MΩ Control; 399 ± 221 MΩ LPS 
4H; 439 ± 246 MΩ LPS 6H). 
GABAergic postsynaptic currents (IPSCs) were recorded at 84 mV holding potential in the 
presence of CNQX (10 μM; Sigma), strychnine (1 μM; Sigma) and APV (25 μM; Sigma). 
Tetrodotoxin (TTX; 1 μM, Latoxan) was used to isolate GABAA-receptor-mediated miniature 
events (mPSCs). GABAA-receptor-mediated PSCs were fully blocked by the application of 10 
μM SR-95531 (Sigma).  
Recordings of the IPSCs at different holding potentials were used to measure the chloride 
equilibrium potential (ECl), which was determined as the x-axis intercepts point of the resulting 
I-V curve extrapolated by linear regression.  
The imidazopyridine zolpidem (Sigma), a benzodiazepine ligand with high selectivity for 
GABAARs containing the 1-subunit and moderate affinity to 2- or 3-subunit, (Maric et al., 
1999), was dissolved in water stock solution (1 mM) and diluted to the concentration of 100 
nM (Chen et al., 2004) in extracellular solution for bath application (15-20 min).  
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Cytokines and chemokines measurement 
TNF-α, IL-4, IL-6, IL-10, INF-γ, CXCL1, and CXCL2 concentrations were measured in 
organotypic culture supernatants by Milliplex assay (Merck Millipore, #MCYTOMAG-70k), 
using the Bio-Plex apparatus (Biorad), according to the manufacturer’s recommendations. 
Statistical analysis 
All values from samples subjected to the same experimental protocols were pooled together 
and results are presented as mean (± S.D., if not otherwise indicated, with n = number of 
neurons, if not otherwise indicated). In box-plots, the thick horizontal bar indicates the median 
value, the boxed area extends from the 25th to 75th percentiles while whiskers from the 5th to 
the 95th percentiles. The homogeneity of variances was assessed through the Levene's test.  
Statistically significant difference between two data sets was assessed by Student's t-test for 
parametric data and by Mann-Whitney for non-parametric ones. Differences between the 
logarithmic values of the analyzed variables were assessed using one-way ANOVA and 
multiple comparisons were adjusted by Tukey correction.  
Statistical significance was abbreviated as follows: *P<0.05, ** P<0.01, *** P<0.001. 
Results 
CKs and LPS differently affect GABAergic transmission in organotypic spinal slices  
We exploited organotypic spinal cord and DRG co-cultures (Fig. 1 A) to model 
neuroinflammation in vitro and to investigate the impact of pro-inflammatory agents on 
neuronal network activity. In particular, we addressed the modulation of inhibitory, 
GABAergic synaptic transmission. We compared two different danger signals to trigger 
neuroinflammation in cultured slices: a pro-inflammatory cocktail of CKs (Medelin et al., 
2018) and LPS. In both conditions, after 4H and 6H treatments (see methods), patched clamped 
ventral interneurons displayed a comparable and significant increase in the frequency of 
spontaneous PSCs (represented by heterogeneous inward currents of variable amplitude), in 
accordance with previous reports (Kawasaki et al., 2008; Zhang et al., 2010; Zhang et al., 
2011; Medelin et al., 2018; Fig. S1 A-D; Control, CKs 4H, and CKs 6H; n = 62, 48, 54, 
respectively; Control, LPS 4H, and LPS 6H; n = 35, 38, 34, respectively 
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Figure 1. CKs and LPS differently affect GABAA receptor-mediated synaptic currents in 
organotypic spinal culture.  
A, Immunofluorescence labelling of organotypic co-cultured DRG and spinal cord slice (2 
WIV), mature neurons and neuronal processes are visualized by SMI-32 (in red) and MAP2 
(in green) markers. The dashed area is shown at higher magnification in the right panels. VH 
= ventral fissure, DH = dorsal horn, DRG = dorsal root ganglia. B, Pharmacologically isolated 
IPSCs recorded from ventral interneurons at 2 WIV. CKs 4H (in red, left) and 6H (in blue, left) 
enhanced IPSC frequency, on the opposite LPS 4H (in red, right) and 6H (in blue, right) did 
not affect IPSCs occurrence. C, Box plots summarized  values from pooled experiments in 
CKs (top) or LPS (bottom), insets show superimposed, averaged IPSCs (same cells as in B), 
note the changes in IPSCs duration in CKs D, Box plots summarized  values from pooled 
experiments in CKs (top) or LPS (bottom), insets show superimposed, averaged mIPSCs, note 
the changes in IPSCs duration in CKs. Box plot are mean ± SD while column graph is mean ± 
SEM analyzed with one-way ANOVA: *P<0.05, ** P<0.01, *** P<0.001. 
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Thus, in spinal explants, global network activity was similarly affected by the two danger 
signals, CKs and LPS. We next focused our attention on the fast Cl- mediated 
neurotransmission due to GABAA receptor activation, a potential CKs target in spinal circuits 
(Kawasaki et al., 2008; Zhou et al., 2011; Zhang and Dougherty, 2011; Medelin et al 2018).  
We recorded GABAA receptor-mediated synaptic events (IPSCs; Fig. 1 B) pharmacologically 
isolated in the presence of CNQX (10 µM), APV (25 µM) and strychnine (1µM). CKs 
treatments (4H and 6H; n = 30, 31; respectively) significantly increased IPSCs frequency (4.9 
± 1.9 Hz CKs 4H; 4.6 ± 2.2 Hz CKs 6H; box plots in Fig. S2 A) when compared to Control 
(3.1 ± 1.6 Hz, n = 35; ***P < 0.001 Control vs CKs 4H and **P = 0.006 vs CKs 6H, one-way 
ANOVA; box plots in Fig. S2 A). Conversely, in LPS treatments (LPS 4H, LPS 6H; n = 34, n 
= 28, respectively; Fig. 1 B, right tracings) IPSCs frequency was slightly, although not 
significantly affected by the inflammatory stimulus (3.0 ± 2.6 Hz LPS 4H; 3.3 ± 2.7 Hz LPS 
6H) when compared to their relative Control (2.0 ± 1.5 Hz, n = 37; box plots in Fig. S2 A). 
We next explored the kinetic properties of the IPSCs. Consistent with our previous findings 
(Medelin et al., 2018), CKs treatments significantly accelerated the IPSCs decay time constant 
(τ) after both CKs 4H and CKs 6H exposures (23.9 ± 6.3 ms CKs 4H; 25.5 ± 6.4 ms CKs 6H; 
Fig. 1 C, top, box plot and inset) when compared to Control (31.8 ± 9.4 ms Control; ***P < 
0.001 CTRL vs CKs4H, ***P < 0.001 Control vs CKs 6H, one-way ANOVA; Fig. 1 C). 
Differently, LPS (4H and 6H) did not modulate the τ of the IPSCs that remained unchanged 
(27.9 ± 7.1 ms LPS 4H; 28.1 ± 6.3 ms LPS 6H) in respect to Control (29.1 ± 7.4 ms Control; 
Fig. 1 C, bottom box plot and inset). The values of IPSCs amplitude (18.0 ± 10.1 pA Control; 
19.1 ± 8.8 pA CKs 4H; 17.7 ± 11.2 pA CKs 6H; 15.7 ± 8.9 pA Control; 11.3 ± 4.5 pA LPS 
4H; 13.1 ± 7.3 pA LPS 6H; Fig. S2 B) and rise time (2.5 ± 0.9 ms Control; 2.1 ± 0.8 ms CKs 
4H; 2.4 ± 1.1 ms CKs 6H; 2.6 ± 1.0 ms Control; 2.5 ± 1.0 ms LPS 4H; 2.6 ± 0.9 ms LPS 6H; 
Fig. S2 C) were unaffected by all treatments. We extended our characterisation to the properties 
of miniature GABAergic currents (mPSCs; recorded in the presence of TTX). The results in 
this group of cells (Fig. 1 D) confirmed that Control and CKs 6H mPSCs differed significantly 
in their decay kinetics (mPSCs τ value: 40.9 ± 11.7 ms Control; 29.4 ± 11.6 ms CKs 4H; 24.3 
± 6.4 ms CKs 6H; n=9, 7, 9, respectively; *P = 0.024 Control vs CKs 6H, one-way ANOVA) 
in a manner similar to that of spontaneous IPSCs. mIPSCs decay time remained unchanged 
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upon LPS treatments (30.2 ± 5.9 ms Control; 29.3 ± 4.3 ms LPS 4H; 30.2 ± 5.3 ms LPS 6H; 
n=5, 5, 5, respectively; Fig. 1D, bottom) in accordance with the spontaneous IPSCs. 
Since IPSCs decay time may be developmentally regulated (Liu and Wong-Riley, 2004), we 
plotted the τ values detected in Control and in CKs 4H and 6H against the time of growth in 
vitro.  Bar plots in Fig. 1 E show that the effects of CKs on the GABAergic current duration 
were effective at any age of maturation in vitro, excluding a correlation between the 
modulation of IPSCs decay time and the developmental stage of spinal cord slices in vitro (13-
15 DIV: 36.3 ± 2.7 ms Control; 26.5 ± 2.2 ms CKs 4H; 24.5 ± 1.6 ms CKs 6H; n=14, 10, 15, 
respectively; *P = 0.011 Control vs CKs 4H; ***P < 0.001 Control vs CKs 6H; 16-17 DIV: 
30.8 ± 2.7 ms Control; 20.9 ± 2.0 ms CKs 4H; 26.3 ± 2.3 ms CKs 6H; n=17, 15, 12, 
respectively; *P = 0.013 Control vs CKs 4H; 20-22 DIV: 37.6 ± 3.6 ms Control; 22.5 ± 2.6 ms 
CKs 4H; 26.2 ± 2.3 ms CKs 6H; n=8, 6, 6, respectively; *P = 0.011 Control vs CKs 4H; *P = 
0.041 Control vs CKs 6H; one-way ANOVA). 
Thus, both CKs and LPS treatments boosted PSCs frequency, but only CKs specifically 
affected the GABAergic synaptic transmission.  
We next examined the presence and distribution of GABAergic neurons 
immunohistochemically targeting either isoforms of GABA-synthesizing enzyme (GAD), 
namely GAD65/67 (Pribiag et al., 2013). We quantified and compared GAD65/67 labelling in 
all conditions (Fig. S3, A-D). Immunoreactivity for GAD65/67 was visible throughout the 
spinal explants where neurons were identified by a specific immunofluorescence marker (class 
III β-tubulin, Fig. S3 A and C). At lower magnification, scattered soma, extensive neural 
processes, and bouton-like structures appeared to be stained for both GAD isoforms and were 
not affected by CKs or LPS treatments, quantified in Fig. S3 B and D.   
 
CKs and LPS promote diverse responses in the spinal explants glial resident-cells 
In response to different microenvironment stimuli, microglia and astrocytes may switch to 
active states, highlighted by changes in cell number and morphology. Microglia and astrocytes 
were visualized in organotypic spinal explants by Iba1 and GFAP co-immunolabelling, shown 
in Fig. 2 A and B.  
CKs 4H and 6H treatments promoted a significant increase in Iba1+ cells (99.8 ± 5.5 cells/mm2 
Control; 155.3 ± 21.5 cells/mm2 CKs 4H; 183.7 ± 15.7 cells/mm2 CKs 6H; *P = 0.032 Control 
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vs CKs 4H; ***P < 0.001 Control vs CKs 6H; one-way ANOVA; Fig. 2 C, left). The same 
treatments promptly induced a significant increase in GFAP intensity (158.1 ± 35.7 % CKs 
4H; 229.3 ± 37.3 % CKs 6H; *P = 0.024 Control vs CKs 4H, ***P < 0.001 vs CKs 6H; ***P 
< 0.001 CKs 4H vs CKs 6H; one-way ANOVA; Fig. 2 C, middle) with no major changes in 
GFAP voxel (119.0 ± 22.4 % CKs 4H; 121.3 ± 37.1 % CKs 6H; Fig. 2 C, right). On the 
opposite, LPS, summarized in the plots in Fig. 2 D, provoked only mild increases in Iba1+ cells 
(100.8 ± 8.2 cell/mm2 Control; 112.8 ± 7.4 cell/mm2 LPS 4H; 132.2 ± 11.7 cell/mm2 LPS 6H), 
and in the GFAP intensity (110.4 ± 18.7 % LPS 4H; 141.1 ± 15.1 % LPS 6H), with no changes 
in GFAP voxel (102.5 ± 4.1% LPS 4H; 99.4 ± 3.3% LPS 6H). These observations suggest that 
CKs, differently from LPS, promoted a significant increase in microglia proliferation and 
astrogliosis in spinal cord cultures.   
 
Figure 2. CKs and LPS induced different tissue reactivity in spinal organotypic slices.  
A-B, Representative confocal images of organotypic spinal slices immunolabelled for Iba1 (in 
red) and GFAP (in green), visualizing microglia and astrocytes, respectively, prior and after 
CKs or LPS treatments (4H and 6H) C, Bar plots summarize Iba1+ cells/mm2, GFAP intensity 
(express as % of control) and GFAP voxel (express as % of control) prior and after CKs 
treatments (4H and 6H). D, Bar plots summarize Iba1+ cells/mm2, GFAP intensity (express as 
% of control) and GFAP voxel (express as % of control) prior and after LPS treatments (4H 
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and 6H). Bar plots report mean values ± SEM analyzed with one-way ANOVA: *P<0.05, ** 
P<0.01, *** P<0.001. 
 
CKs and LPS modulate microglia morphology with opposite effects on cell complexity    
In this set of experiments, we assessed CKs and LPS ability to shape the morphology of Iba1+ 
cells. To this aim, we quantified the total dendrites length, an accepted index to measure the 
cellular processes growth (Sidharth et al., 2011), and the ratio between dendrite end- and 
attachment-points, a measure of the degree of ramification within each dendrite branching of 
Iba1+ cell (Fig. 3 A and B). Upon CKs 4H and 6H treatments, microglia (Fig. 3 A) showed a 
significant decrease in both the total dendrite lengths (270.3 ± 144.8 µm Control; 99.7 ± 65.6 
µm CKs 4H; 93.8 ± 81.2 µm CKs 6H; ***P < 0.001 Control vs CKs 4H; ***P < 0.001 Control 
vs CKs 6H; one-way ANOVA; Fig. 3 C, top) and end/attachment points ratio (2.4 ± 1.4 
Control; 1.2 ± 0.4 CKs 4H; 1.2 ± 0.5 CKs 6H; ***P < 0.001 Control vs CKs 4H; ***P < 0.001 
Control vs CKs 6H; one-way ANOVA; Fig. 3 C, bottom). These changes are indicative of a 
switch in microglia morphology from the ramified shape to the amoeboid one. In parallel, in 
slices stimulated by LPS, we observed opposite changes in cell morphology. In fact, Fig. 3 A 
and D show a significant increment of the Iba1+ cell dendrites at LPS 6H (346.6 ± 194.9 µm 
Control; 306.1 ± 126.2 µm LPS 4H; 472.6 ± 255.9 µm LPS 6H; ***P < 0.001 Control vs LPS 
6H; ***P < 0.001 LPS 4H vs LPS 6H; one-way ANOVA) with no reduction in the ramification 
of dendritic branching (2.6 ± 1.3 Control; 2.3 ± 1.1 LPS 4H; 2.7 ± 1.3 LPS 6H). Finally, we 
evaluated and compared the production of cytokines and chemokines by spinal slices in 
response to pro-inflammatory stress. The summarizing plots of Fig. 3 E show that the exposure 
to CKs (top) and LPS (bottom) significantly increased the release of pro-inflammatory 
cytokines, measured in the supernatant, such as TNF-α (in LPS), IL-6, INF-γ (in both LPS and 
CKs), as well as the release of chemokines including CXCL1 and CXCL2 necessary for the 
recruitment of innate immune cells (*0.01 < P < 0.05; **0.001 < P < 0.01; ***P < 0.001, n=14, 
one-way ANOVA). On the other hand, IL-4 and IL-10 are significantly raised upon CKs 
stimuli, while a reduction in IL-4 accompanied by no changes in IL-10 levels were detected 
after LPS treatments. The release of pro- and anti-inflammatory cytokines, in addition to the 
production of chemokines, suggests that the activation of inflammatory mechanisms, although 
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different, occurred in spinal slices stimulated by both CKs and LPS at any time point (4H and 
6H).  
 
Figure 3. Microglia morphology is differentially modulated by CKs and LPS treatments 
in organotypic slices.  
A, Representative confocal images comparing Iba1 immunolabelling in untreated (control), 
CKs and LPS treated cultures (4H and 6H). B, High magnification confocal micrograph 
illustrates the morphological analysis: dendrites length and their end/attachment points are 
indicated by arrows. C-D, Plots summarize the measured parameters in pooled experiments, 
note the significant decrease in total dendrites length and end/attachment points ratio upon CKs 
4H and 6H (C), on the opposite, a significant increase in total dendrites length is reported at 
LPS 6H with no changes in end/attachment point ratio (D). E, Production of cytokines (TNF-
α; IL-4; IL-6; IL-10; INF-γ) and chemokines (CXCL1; CXCL2) determined by Milliplex assay 
in organotypic culture supernatants after incubation with CKs (top) and LPS (bottom) for 4H 
or 6H. Column graphs report mean values ± SEM of 22 and 14 independent experiments 
respectively analyzed with one-way ANOVA: *P<0.05, ** P<0.01, *** P<0.001. 
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Prolonged exposure to LPS does not change the spinal tissue response  
In the central nervous system LPS binds to the Toll-like receptors (TLRs), especially TLR4, 
expressed on the microglia surface. This signal involves several proteins resulting in the 
production and release of cytokines, chemokines and other inflammatory factors (Rahimifard 
et al., 2017). Since LPS, differently from CKs (Maria Schäfers and Linda Sorkin, 2008), does 
not act directly on neurons, we tested whether a longer (24H) exposure to LPS may ultimately 
lead to changes in GABAergic transmission and kinetic. Fig. 4 reports the effects of LPS 24H 
in terms of PSCs frequency (21.7 ± 6.7 Hz Control; 30.5 ± 5.0 Hz LPS 24H; n = 8 and 12, 
respectively; **P = 0.003 Control vs LPS 24H; Student’s t-test; Fig. 4 A), IPSCs frequency 
(1.2 ± 0.8 Hz Control; 2.5 ± 0.9 Hz LPS 24H; **P = 0.007 Control vs LPS 24H; Student’s t-
test; Fig. 4 B) and IPSCs decay time constant (32.7 ± 10.2 ms Control; 29.7 ± 5.5 ms LPS 24H, 
Fig. 4 C, scaled averaged IPSCs are superimposed in the inset). In addition, Iba1+ cells at LPS 
24H (Fig. 4 D) displayed the characteristic morphology with longer branching in ramified cells 
(quantified in plots of Fig. 4 D, total dendrites length: 249.6 ± 96.0 µm Control; 393.4 ± 216.9 
µm LPS 24H; ***P < 0.001 Control vs LPS 24H; Student’s t-test; end/attachment points ratio: 
1.2 ± 1.5 Control; 1.3 ± 1.5 LPS 24H) in the absence of changes in terms of Iba1+ cells (53.1 
± 2.9 cells/mm2 Control; 55.3 ± 2.9 cells/mm2 LPS 24H). These results indicated that while the 
trend in increasing IPSCs frequency brought about by LPS turned into a significant change 
upon prolonged exposure (compare Fig. S2 A to Fig. 4 B), the kinetic of GABAergic currents 
was not modulated by longer danger signal, and the effects on microglia dendrite lengths 
stabilized after 6H.  
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Figure 4. LPS-prolonged exposure in organotypic spinal slices does not alter IPSCs 
decay.  
A, Representative traces of spontaneous PSCs recorded from control (in black) and LPS 24H 
(in orange) ventral interneurons. Polled data are summarized by the box plot showing a 
significant increase of PSCs frequency upon LPS 24H. B, Pharmacologically isolated IPSCs 
are recorded from control (in black) and LPS 24H (in orange) ventral interneuron (same cells 
as in A). The box plot summarizes the IPSCs frequency from pooled experiments and exhibits 
a significant increased frequency brought about by LPS 24H. C, The boxplot summarizes the 
values of  for control and LPS, in the inset averaged, scaled, superimposed traces of the two 
conditions are shown. Note that no changes were detected in IPSCs decay time constant. D, 
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Left, representative image of the LPS 24H-treated organotypic culture labelled with GFAP 
(green) and Iba1 (red). High magnification Iba1 micrographs are shown (middle), and plots 
summarize the morphology changes of microglia at LPS 24H. Note the significant increase in 
total dendrites length (top). 
CKs modulate GABAergic current duration by tuning GABAAR subunit composition 
We found that GABAA-PSCs from 4H and 6H CKs slices, but not from LPS ones, decayed 
faster than those from Controls (Medelin et al., 2018). This tuning in inhibitory synaptic signals 
appears specifically exerted by CKs-induced neuroinflammation. We further investigated in 
the present work the mechanisms responsible for this effect on the kinetic properties of 
GABAergic receptors and therefore the GABAA-PSC time course. Our results on mIPSCs 
excluded the involvement of presynaptic processes (such as GABA release synchronization) 
that may affect synaptic time course, in fact, the decay of IPSCs is also faster for unitary 
synaptic events (mPSCs). 
We addressed whether differences in the intracellular chloride concentration [Cl-]i might affect 
IPSC kinetics (Funk et al., 2008; Moroni et al., 2011).  
We incubated the slices with Bumetanide (10 μM; 24H), a pharmacological agent that blocks 
the activity of NKCC1, the most abundant co-transporter membrane-protein determining 
intracellular chloride levels (Ben-Ari, 2017), to experimentally reduce [Cl-]i prior to CKs 4H 
(see sketch of the experimental settings in Fig. 5 A). 
Bumetanide per se induced an increase in PSCs and IPSCs frequencies that were not 
significantly improved by CKs 4H (Fig. 5 B and Fig. S4).  More intriguingly, Bumetanide 
reduced significantly the duration of GABAergic currents that were not further shortened by 
CK 4H (33.1 ± 8.1 ms Control; 22.3 ± 6.2 ms BUM 24H; 22.3 ± 6.5 ms BUM 24H + CKs 4H; 
n=10, 11, 10, respectively; **P = 0.005 Control vs BUM 24H; *P = 0.012 Control vs BUM 
24H + CKs 4H; one-way ANOVA; Fig. 5 C).  
Fig. 5 D shows the measurement of the reversal potential of IPSCs in Control, Bumetanide and 
Bumetanide plus CKs 4H. The ECl value in Control (–48.5 ± 3.7 mV; n = 7) was close to the 
approximate theoretical value expected for the Cl− equilibrium potential for our intracellular 
and extracellular chloride concentrations (–50 mV; Medelin et al., 2016). However, the 
reversal potential was significantly shifted to more negative values by blocking NKCC1 (–54.2 
± 4.3 mV BUM 24H, n = 8; *P = 0.025 Control vs BUM 24H; one-way ANOVA), suggesting 
that local intracellular chloride concentrations are lower. It is important to note that in 
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organotypic cultures, upon Bumetanide treatments, the Cl− reversal potential differed from the 
predicted theoretical value, suggesting a real shift in the internal chloride concentration as a 
result of improved extrusion (DeFazio et al., 2000; Ostroumov et al., 2011), regardless the 24 
mM Cl− intracellular pipette solution. 
Pro-inflammatory CKs, in the presence of NKCC1 block, slightly increased such a shift (–56.2 
± 3.5 mV BUM 24H + CKs 4H; n = 8; **P = 0.003 Control vs BUM 24H + CKs 4H; one-way 
ANOVA). The absence of significant changes in IPSCs decay time constant and reversal 
potential when CKs were incubated in the presence of Bumetanide might indicate an occluding 
mechanisms in regulating [Cl-]i.  
To shed light in CKs potential regulation of intracellular chloride, and thus of IPSCs , we 
estimated and compared ECl in CKs and LPS treatments. Fig. 5 E and F show that the reversal 
potential of IPSCs was not altered by these treatments alone (–52.0 ± 7.5 mV Control; –51.5 ± 
5.2 mV CKs 4H; –54.1 ± 6.0 mV CKs 6H; n = 9, 10, 8, respectively; –49.6 ± 7.8 mV Control; 
–49.7 ± 9.9 mV LPS 4H; –52.3 ± 6.0 mV LPS 6H; n = 13, 8, 8, respectively). Regardless the 
similar ECl extrapolated in all the recording conditions, only CKs 4H and 6H induced the 
expected changes in the IPSCs duration ( = 31.8 ± 5.1 ms Control; 23.9 ± 8.1 ms CKs 4H; 
20.7 ± 3.4 ms CKs 6H; n=9, 10, 8, respectively; *P = 0.031 Control vs CKs 4H; **P = 0.003 
Control vs CKs 6H; one-way ANOVA;  = 26.4 ± 5.2 ms Control; 26.2 ± 6.3 ms LPS 4H; 27.5 
± 6.9 ms LPS 6H; n=13, 8, 8, respectively). These results show that changes in ECl might indeed 
modulate IPSCs duration in the organotypic spinal interneurons, however, CKs apparently are 
not tuning the inhibitory current duration by shifts in the ECl. 
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Figure 5. Bumetanide but not CKs and LPS affected the IPSCs reversal potential in 
organotypic slices  
A, Sketch of the protocol used to treat slices with bumetanide for 24H (BUM 24H) followed 
by CKs 4H. B, Representative traces (left) and superimposed isolated events (right) of IPSCs 
in control, after BUM 24H (green), and BUM 24H + CKs 4H (magenta) ventral interneurons. 
C, The boxplot summarizes the  values measured in the three conditions, note the similar and 
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significant reduction in  at BUM 24H and BUM 24H + CKs 4H; in the inset superimposed 
averaged and scaled IPSCs in the three conditions. D, IPSCs averaged and superimposed traces 
(top) recorded at different Vh in control (black), BUM 24H (green) and BUM 24H + CKs 4H 
(magenta). I–V curves were obtained by plotting GABAA-PSCs mean amplitude against Vh. 
Note the significant differences in the approximate calculated reversal potential at BUM 24H 
and BUM 24H + CKs 4H compared to control. E, IPSCs averaged and superimposed traces 
(top) recorded at different Vh in control (black), CKs 4H (red) and CKs 6H (blue). I–V curves 
were obtained by plotting GABAA-PSCs mean amplitude against Vh. Note the similar 
approximate calculated reversal potential in all conditions. F, IPSCs averaged and 
superimposed traces (top) recorded at different Vh in control (black), LPS 4H (red) and LPS 
6H (blue). I–V curves were obtained by plotting GABAA-PSCs mean amplitude against Vh. 
Note the similar approximate calculated reversal potential in all conditions. 
 
Another well-documented process that changes GABAergic inhibition is the switch in the α1-
subunit expression that is traditionally associated with a modulation in IPSCs kinetics, which 
become faster (Vicini et al. 2001). To address the potential changes in the receptor subunit 
composition due to CKs treatment, we tested IPSCs kinetics in the presence of Zolpidem (100 
nM; 15-20 min), an allosteric modulator of GABAAR subunits that at low concentration is 
highly selectively for the GABAAR α1 subunit (Perrais and Ropert et al., 1999). Fig. 6 A shows 
sample superimposed isolated IPSCs recorded from Control, CKs 4H, and CKs 6H, before and 
after Zolpidem applications. After CKs 4H and 6H, IPSCs  was, as expected, significantly 
reduced (33.3 ± 4.5 ms Control; 25.4 ± 4.7 ms CKs 4H; 26.0 ± 4.0 ms CKs 6H; n=9, 10, 9, 
respectively; *P = 0.019 Control vs CKs 4H; *P = 0.045 Control vs CKs 6H). Subsequent 
applications of Zolpidem did not alter IPSCs  in Control (36.3 ± 3.9 ms), while significantly 
prolonged  values detected in CK 4H and 6H (34.5 ± 6.9 ms CKs 4H; 34.2 ± 6.0 ms CKs 6H; 
**P = 0.003 CKs 4H -Zolpidem vs CKs 4H +Zolpidem; *P = 0.017 CKs 6H -Zolpidem vs 
CKs 6H +Zolpidem; two-way ANOVA) which did not differ anymore from Control IPSCs 
(summarized in plots of Fig. 6 B). These results strongly suggest that CKs treatments regulated 
the duration of GABAergic inhibition via postsynaptic changes of the α1 subunit.  
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Figure 6. Block of GABAA receptor α1 subunit by Zolpidem prolonged IPSCs in CKs but 
not in control.  
A, Superimposed IPSCs recorded in control and CKs (4H and 6H) in the presence or in the 
absence of zolpidem. Averaged IPSCs are shown in black (control, left), in red (CKs 4H, 
middle) and in blue (CKs 6H, right) B, Bar plot summarizes the values of  in Control, CKs 
4H, and CKs 6H IPSCs, before and after bath application of zolpidem. Note that the significant 
decrease in IPSCs  upon CKs treatments (4H and 6H) was reversed by zolpidem. In the inset: 
the plot summarizes the % of τ increase in zolpidem, note the increase by 8.71% in control, by 
34.09% in CKs 4H, and by 31.69% in CKs 6H.  
 
 
 
 
81 
Conclusions 
Together, these results suggest that the CKs specifically regulate post-synaptically the efficacy 
of GABAergic inhibition in spinal ventral interneurons. Such a regulation of spinal pre-motor 
interneuron activity implies a modulation of GABAA subunit expression and may impair spinal 
network operation. Shortening of IPSCs together with microglia and astrocytes activation may 
represent a specific mechanism of certain CKs combinations, potentially a targetable pathway 
in spinal neuroinflammatory diseases. 
Abbreviations  
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Supplementary Figures 
 
Supplementary Figure S1. CKs and LPS significantly increased spontaneous PSCs in 
organotypic slices. 
A-B, Representative traces of PSCs in control (black), upon incubation in CKs (4H red and 6H 
blue; left) and in LPS (4H red and 6H blue; right). C-D, Box plots summarize the frequency 
values recorded in all conditions. 
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Supplementary Figure S2. CKs and LPS impact on pharmacologically isolated GABAA 
receptor-mediated IPSCs.  
A-C, Box plots illustrate the mean value of IPSCs frequency, amplitude and rise time upon 
CKs and LPS treatments. A significant increase is observed only in the IPSCs frequency at 
CKs 4H and 6H compared to control.  
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Supplementary Figure S3. GAD65/67 distribution in organotypic slices treated by CKs 
and LPS. 
A, C, Representative images of spinal slices labelled for β-tubulin III (in blue) and GAD65/67 
(in red) show GABAergic neurons and processes B, D, Bar plots summarize the number of 
GAD65/67 voxel, the number of cluster and the cluster intensity in all conditions. Note the 
absence of changes in any measured parameter. 
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Supplementary Figure S4. Spontaneous PSCs and IPSCs frequency after bumetanide 
24H and in bumetanide plus CKs.  
A, Quantification of PSCs frequency recorded from control, bumetanide-treated slices prior 
and after CKs. Note the significant increase in PSCs frequency BUM 24H and BUM 24H + 
CKs 4H compared to control. B, Bar plots summarized a significant increase in IPSCs 
frequency upon BUM 24H and BUM 24H + CKs 4H compared to control.  
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Conclusion 
Neuroinflammation is a powerful mechanism used by the CNS as defence, which is typically 
activated in response to damage and infection. A non-resolution of the inflammatory processes 
lead to a chronic phase that represents a key event in several neurodegenerative diseases. In 
this work, we further confirmed organotypic spinal slices as a good model to test the spinal 
network synaptic activity during neuroinflammatory stress due to the easy access to pre-motor 
interneurons with electrophysiological techniques. Especially, these complex tissue maintains 
the basic spinal cord architecture as well as the neuronal and glial resident cells. This represents 
an essential feature to investigate the neuronal excitability and specific synaptic changes of a 
precise region of interest under physiological and pathological condition.  
The principal findings of this work is that in CKs-treated slices, the interneuronal GABAergic 
transmission is affected, resulting in an impaired in the pre-motor spinal circuits. This effect 
was exclusively mediated by CKs, in contrast to LPS, which did not affect the GABAAR 
kinetic. Our data support the hypothesis that CKs act by post-synaptic modification resulting 
in the inhibitory transmission alteration.  
A part from the intrinsic synaptic activity, environmental factors are surely able to trigger 
neuronal dysregulation and among them, we decided to focus, therefore, on glial cells. An 
essential contribution in neuroinflammatory disorders is mediated by microglia and astrocytes, 
which represents the principal mediators of the inflammatory response. In fact, depending on 
different stimuli (CKs or LPS) they show distinct behaviour that reflects the alteration exhibits 
by spinal interneurons in their synaptic activity.  
Furthermore, we investigated the mechanisms by which pro-inflammatory cytokines induce 
modification on the inhibitory component, and in particular, we assessed two processes capable 
of modifying the GABAAR kinetic: changes in the intracellular chloride concentration ([Cl
-]i) 
and receptor subunit composition. Despite CKs induce faster GABAergic synaptic currents, 
they do not affect the [Cl-]i  excluding the hypothesis of a possible action on the chloride 
homeostasis. Moreover, using Zolpidem a selective modulator of the α1 subunit we restored 
the regular GABAAR kinetic. These results clarify the path by which CKs are able to modulate 
mechanisms such as synthesis, trafficking, or assembling associated with the GABAAR 
subunits. 
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In conclusion, expanded our knowledge about the communication between 
neuroinflammation, glial cells and neuronal spinal networks. Furthermore, understanding the 
molecular pathways that promote the dysregulation of inhibitory spinal synaptic represents a 
future perspective to produce new therapies that could be essential for the spinal 
neurodegeneration disorders.  
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